| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | RAMP1 HTR2B HTR2C GPR39 FFAR1 GPR84 CCRL2 S1PR2 TNFRSF18 GRIN2C TAAR8 GPR101 GRM2 IL18R1 EDNRA IFNAR1 IFNGR1 CCR2 TYRO3 ADGRG7 ADRA1B OR10AG1 ADRA2A ADRA2C OR5AC2 FCGR1A FCGR1BP ADGRG2 OR51I1 OR51B6 OR6C75 PKD1 GPR156 CCR3 TACR2 ROS1 CCR5 CCR7 RXFP1 GRIN3B NMBR ADGRL2 IL17RD ACKR1 ENG OR52B2 GPR119 ADGRD1 OR2H2 | 3.21e-18 | 1353 | 174 | 49 | GO:0004888 |
| GeneOntologyMolecularFunction | G protein-coupled receptor activity | RAMP1 HTR2B HTR2C GPR39 FFAR1 GPR84 CCRL2 S1PR2 TAAR8 GPR101 GRM2 EDNRA CCR2 ADGRG7 ADRA1B OR10AG1 ADRA2A ADRA2C OR5AC2 ADGRG2 OR51I1 OR51B6 OR6C75 GPR156 CCR3 TACR2 CCR5 CCR7 RXFP1 NMBR ADGRL2 ACKR1 OR52B2 GPR119 ADGRD1 OR2H2 | 6.63e-15 | 884 | 174 | 36 | GO:0004930 |
| GeneOntologyMolecularFunction | benzodiazepine receptor binding | 2.77e-08 | 5 | 174 | 4 | GO:0030156 | |
| GeneOntologyMolecularFunction | C-C chemokine binding | 4.75e-08 | 24 | 174 | 6 | GO:0019957 | |
| GeneOntologyMolecularFunction | cytokine binding | CCRL2 IL18R1 IFNAR1 IFNGR1 CCR2 CCR3 CCR5 CCR7 ACKR1 ENG HYAL2 | 1.33e-07 | 157 | 174 | 11 | GO:0019955 |
| GeneOntologyMolecularFunction | cytokine receptor activity | 1.74e-07 | 97 | 174 | 9 | GO:0004896 | |
| GeneOntologyMolecularFunction | immune receptor activity | CCRL2 IL18R1 IFNAR1 IFNGR1 CCR2 FCGR1A FCGR1BP CCR3 CCR5 CCR7 IL17RD | 2.21e-07 | 165 | 174 | 11 | GO:0140375 |
| GeneOntologyMolecularFunction | chemokine binding | 3.66e-07 | 33 | 174 | 6 | GO:0019956 | |
| GeneOntologyMolecularFunction | transporter activity | CACNA1A SLC2A9 TSPOAP1 MFSD2B ATP8B1 GRIN2C ATP9A SLC7A7 SLC7A6 SLC30A2 SLC10A7 ATP10A SLC1A4 CALHM4 CALHM2 ABCB1 SLC8A1 SLC7A3 SLC22A3 PKD1 SLC49A3 ATP11A GRIN3B ATP12A SLC2A12 ATP2B1 SVOP SLC37A4 SLC25A17 SLC39A7 | 7.35e-07 | 1289 | 174 | 30 | GO:0005215 |
| GeneOntologyMolecularFunction | G protein-coupled amine receptor activity | 1.40e-06 | 41 | 174 | 6 | GO:0008227 | |
| GeneOntologyMolecularFunction | C-C chemokine receptor activity | 1.41e-06 | 23 | 174 | 5 | GO:0016493 | |
| GeneOntologyMolecularFunction | G protein-coupled chemoattractant receptor activity | 2.69e-06 | 26 | 174 | 5 | GO:0001637 | |
| GeneOntologyMolecularFunction | chemokine receptor activity | 2.69e-06 | 26 | 174 | 5 | GO:0004950 | |
| GeneOntologyMolecularFunction | ATPase-coupled intramembrane lipid transporter activity | 3.96e-06 | 28 | 174 | 5 | GO:0140326 | |
| GeneOntologyMolecularFunction | glycerophospholipid flippase activity | 5.21e-06 | 14 | 174 | 4 | GO:0140333 | |
| GeneOntologyMolecularFunction | floppase activity | 9.34e-06 | 16 | 174 | 4 | GO:0140328 | |
| GeneOntologyMolecularFunction | transmembrane transporter activity | CACNA1A SLC2A9 TSPOAP1 MFSD2B GRIN2C SLC7A7 SLC7A6 SLC30A2 SLC10A7 SLC1A4 CALHM4 CALHM2 ABCB1 SLC8A1 SLC7A3 SLC22A3 PKD1 SLC49A3 GRIN3B ATP12A SLC2A12 ATP2B1 SVOP SLC37A4 SLC25A17 SLC39A7 | 1.18e-05 | 1180 | 174 | 26 | GO:0022857 |
| GeneOntologyMolecularFunction | flippase activity | 1.21e-05 | 17 | 174 | 4 | GO:0140327 | |
| GeneOntologyMolecularFunction | alpha-adrenergic receptor activity | 1.28e-05 | 6 | 174 | 3 | GO:0004936 | |
| GeneOntologyMolecularFunction | phosphatidylcholine floppase activity | 3.53e-05 | 8 | 174 | 3 | GO:0090554 | |
| GeneOntologyMolecularFunction | organic anion transmembrane transporter activity | GRIN2C SLC7A7 SLC7A6 SLC10A7 SLC1A4 ABCB1 SLC7A3 SLC22A3 GRIN3B SLC37A4 SLC25A17 | 5.45e-05 | 293 | 174 | 11 | GO:0008514 |
| GeneOntologyMolecularFunction | secondary active transmembrane transporter activity | SLC2A9 MFSD2B SLC7A6 SLC30A2 SLC10A7 SLC1A4 SLC8A1 SLC22A3 SLC2A12 SLC37A4 SLC25A17 | 5.98e-05 | 296 | 174 | 11 | GO:0015291 |
| GeneOntologyMolecularFunction | adrenergic receptor activity | 7.46e-05 | 10 | 174 | 3 | GO:0004935 | |
| GeneOntologyMolecularFunction | high-affinity IgG receptor activity | 7.55e-05 | 2 | 174 | 2 | GO:0019771 | |
| GeneOntologyMolecularFunction | leukotriene receptor binding | 7.55e-05 | 2 | 174 | 2 | GO:0031774 | |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | SLC2A9 MFSD2B SLC7A6 SLC30A2 SLC10A7 SLC1A4 ABCB1 SLC8A1 SLC22A3 ATP12A SLC2A12 ATP2B1 SLC37A4 SLC25A17 | 7.83e-05 | 477 | 174 | 14 | GO:0022804 |
| GeneOntologyMolecularFunction | intramembrane lipid transporter activity | 8.06e-05 | 51 | 174 | 5 | GO:0140303 | |
| GeneOntologyMolecularFunction | organic cation transmembrane transporter activity | 8.70e-05 | 83 | 174 | 6 | GO:0015101 | |
| GeneOntologyMolecularFunction | G protein-coupled peptide receptor activity | 1.67e-04 | 133 | 174 | 7 | GO:0008528 | |
| GeneOntologyMolecularFunction | L-arginine transmembrane transporter activity | 1.74e-04 | 13 | 174 | 3 | GO:0061459 | |
| GeneOntologyMolecularFunction | alpha2-adrenergic receptor activity | 2.25e-04 | 3 | 174 | 2 | GO:0004938 | |
| GeneOntologyMolecularFunction | chemokine (C-C motif) ligand 5 binding | 2.25e-04 | 3 | 174 | 2 | GO:0071791 | |
| GeneOntologyMolecularFunction | Gq/11-coupled serotonin receptor activity | 2.25e-04 | 3 | 174 | 2 | GO:0001587 | |
| GeneOntologyMolecularFunction | peptide receptor activity | 2.30e-04 | 140 | 174 | 7 | GO:0001653 | |
| GeneOntologyMolecularFunction | amino acid transmembrane transporter activity | 3.17e-04 | 105 | 174 | 6 | GO:0015171 | |
| GeneOntologyMolecularFunction | calcium ion transmembrane transporter activity | 3.64e-04 | 151 | 174 | 7 | GO:0015085 | |
| GeneOntologyMolecularFunction | carboxylic acid transmembrane transporter activity | 4.75e-04 | 207 | 174 | 8 | GO:0046943 | |
| GeneOntologyMolecularFunction | organic acid transmembrane transporter activity | 4.90e-04 | 208 | 174 | 8 | GO:0005342 | |
| GeneOntologyMolecularFunction | basic amino acid transmembrane transporter activity | 6.65e-04 | 20 | 174 | 3 | GO:0015174 | |
| GeneOntologyMolecularFunction | phosphatidylcholine transporter activity | 6.65e-04 | 20 | 174 | 3 | GO:0008525 | |
| GeneOntologyMolecularFunction | sphingolipid transporter activity | 6.65e-04 | 20 | 174 | 3 | GO:0046624 | |
| GeneOntologyMolecularFunction | collagen binding | 7.12e-04 | 81 | 174 | 5 | GO:0005518 | |
| GeneOntologyMolecularFunction | phosphatidylserine flippase activity | 7.42e-04 | 5 | 174 | 2 | GO:0140346 | |
| GeneOntologyMolecularFunction | interferon receptor activity | 7.42e-04 | 5 | 174 | 2 | GO:0004904 | |
| GeneOntologyMolecularFunction | integrin binding | 8.76e-04 | 175 | 174 | 7 | GO:0005178 | |
| GeneOntologyMolecularFunction | virus receptor activity | 8.87e-04 | 85 | 174 | 5 | GO:0001618 | |
| GeneOntologyMolecularFunction | exogenous protein binding | 9.35e-04 | 86 | 174 | 5 | GO:0140272 | |
| GeneOntologyMolecularFunction | phosphatidylcholine flippase activity | 1.11e-03 | 6 | 174 | 2 | GO:0140345 | |
| GeneOntologyMolecularFunction | epinephrine binding | 1.11e-03 | 6 | 174 | 2 | GO:0051379 | |
| GeneOntologyMolecularFunction | aminophospholipid flippase activity | 1.54e-03 | 7 | 174 | 2 | GO:0015247 | |
| GeneOntologyMolecularFunction | IgG receptor activity | 1.54e-03 | 7 | 174 | 2 | GO:0019770 | |
| GeneOntologyMolecularFunction | phosphatidylethanolamine flippase activity | 1.54e-03 | 7 | 174 | 2 | GO:0090555 | |
| GeneOntologyMolecularFunction | glutamate receptor activity | 1.63e-03 | 27 | 174 | 3 | GO:0008066 | |
| GeneOntologyMolecularFunction | lipid transporter activity | 1.69e-03 | 196 | 174 | 7 | GO:0005319 | |
| GeneOntologyMolecularFunction | NMDA glutamate receptor activity | 2.04e-03 | 8 | 174 | 2 | GO:0004972 | |
| GeneOntologyMolecularFunction | symporter activity | 2.04e-03 | 150 | 174 | 6 | GO:0015293 | |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | CACNA1A SLC2A9 TSPOAP1 GRIN2C SLC30A2 CALHM4 CALHM2 SLC8A1 SLC22A3 PKD1 GRIN3B ATP12A ATP2B1 SLC39A7 | 2.08e-03 | 664 | 174 | 14 | GO:0008324 |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | CACNA1A TSPOAP1 GRIN2C SLC30A2 SLC8A1 SLC22A3 PKD1 GRIN3B ATP12A ATP2B1 SLC39A7 | 2.61e-03 | 465 | 174 | 11 | GO:0046873 |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity involved in regulation of cytosolic calcium levels | 2.61e-03 | 9 | 174 | 2 | GO:0099511 | |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity involved in regulation of presynaptic cytosolic calcium levels | 2.61e-03 | 9 | 174 | 2 | GO:0099626 | |
| GeneOntologyMolecularFunction | L-lysine transmembrane transporter activity | 2.61e-03 | 9 | 174 | 2 | GO:0015189 | |
| GeneOntologyMolecularFunction | phosphatidylserine floppase activity | 2.61e-03 | 9 | 174 | 2 | GO:0090556 | |
| GeneOntologyMolecularFunction | L-amino acid transmembrane transporter activity | 3.44e-03 | 71 | 174 | 4 | GO:0015179 | |
| GeneOntologyMolecularFunction | coreceptor activity | 3.61e-03 | 72 | 174 | 4 | GO:0015026 | |
| GeneOntologyMolecularFunction | IgG binding | 3.94e-03 | 11 | 174 | 2 | GO:0019864 | |
| GeneOntologyMolecularFunction | phospholipid transporter activity | 3.99e-03 | 74 | 174 | 4 | GO:0005548 | |
| GeneOntologyMolecularFunction | transmembrane transporter binding | 4.02e-03 | 172 | 174 | 6 | GO:0044325 | |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | CACNA1A SLC2A9 TSPOAP1 GRIN2C SLC30A2 SLC1A4 CALHM4 CALHM2 SLC8A1 SLC22A3 PKD1 GRIN3B ATP12A ATP2B1 SLC39A7 | 4.06e-03 | 793 | 174 | 15 | GO:0015075 |
| GeneOntologyMolecularFunction | guanyl-nucleotide exchange factor activity | 4.21e-03 | 231 | 174 | 7 | GO:0005085 | |
| GeneOntologyMolecularFunction | PDZ domain binding | 4.48e-03 | 123 | 174 | 5 | GO:0030165 | |
| GeneOntologyMolecularFunction | calcium channel activity | 5.48e-03 | 129 | 174 | 5 | GO:0005262 | |
| GeneOntologyMolecularFunction | catecholamine binding | 5.53e-03 | 13 | 174 | 2 | GO:1901338 | |
| GeneOntologyMolecularFunction | serotonin binding | 5.53e-03 | 13 | 174 | 2 | GO:0051378 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water | 5.53e-03 | 13 | 174 | 2 | GO:0016717 | |
| GeneOntologyBiologicalProcess | G protein-coupled receptor signaling pathway | RAMP1 HTR2B HTR2C GPR39 FFAR1 MFSD2B GPR84 CCRL2 S1PR2 TAAR8 GPR101 GRM2 EDNRA CCR2 TYRO3 ADGRG7 ADRA1B OR10AG1 ADRA2A ADRA2C OR5AC2 GRID2IP ADGRG2 OR51I1 OR51B6 OR6C75 GPR156 CCR3 TACR2 CCR5 CCR7 RXFP1 NMBR ADGRL2 ACKR1 OR52B2 GPR119 ADGRD1 HTT OR2H2 | 7.57e-12 | 1395 | 176 | 40 | GO:0007186 |
| GeneOntologyBiologicalProcess | intracellular monoatomic cation homeostasis | SLAMF8 CACNA1A HTR2B HTR2C TSPOAP1 GPR39 AP3B1 STEAP2 SLC30A2 SLC10A7 EDNRA DMXL1 CCR2 NPTN SLC8A1 GRID2IP TMPRSS3 CCR5 CCR7 ATP12A ATP2B1 SLC37A4 SLC39A7 HTT | 4.81e-10 | 611 | 176 | 24 | GO:0030003 |
| GeneOntologyBiologicalProcess | intracellular monoatomic ion homeostasis | SLAMF8 CACNA1A HTR2B HTR2C TSPOAP1 GPR39 AP3B1 STEAP2 SLC30A2 SLC10A7 EDNRA DMXL1 CCR2 NPTN SLC8A1 GRID2IP TMPRSS3 CCR5 CCR7 ATP12A ATP2B1 SLC37A4 SLC39A7 HTT | 6.87e-10 | 622 | 176 | 24 | GO:0006873 |
| GeneOntologyBiologicalProcess | intracellular chemical homeostasis | SLAMF8 CACNA1A HTR2B HTR2C TSPOAP1 GPR39 HMGCR GRM2 AP3B1 STEAP2 SLC30A2 SLC10A7 EDNRA DMXL1 CCR2 NPTN SLC8A1 ADRA2A ORMDL3 GRID2IP TMPRSS3 CCR5 CCR7 ATP12A ATP2B1 SLC37A4 SLC39A7 HTT | 1.24e-09 | 866 | 176 | 28 | GO:0055082 |
| GeneOntologyBiologicalProcess | monoatomic cation homeostasis | SLAMF8 CACNA1A HTR2B HTR2C TSPOAP1 GPR39 AP3B1 STEAP2 SLC30A2 SLC10A7 EDNRA DMXL1 CCR2 NPTN SLC8A1 GRID2IP TMPRSS3 CCR5 CCR7 ATP12A ATP2B1 SLC37A4 SLC39A7 HYAL2 HTT | 1.66e-09 | 705 | 176 | 25 | GO:0055080 |
| GeneOntologyBiologicalProcess | monoatomic ion homeostasis | SLAMF8 CACNA1A HTR2B HTR2C TSPOAP1 GPR39 AP3B1 STEAP2 SLC30A2 SLC10A7 EDNRA DMXL1 CCR2 NPTN SLC8A1 GRID2IP TMPRSS3 CCR5 CCR7 ATP12A ATP2B1 SLC37A4 SLC39A7 HYAL2 HTT | 2.34e-09 | 717 | 176 | 25 | GO:0050801 |
| GeneOntologyBiologicalProcess | inorganic ion homeostasis | CACNA1A HTR2B HTR2C TSPOAP1 GPR39 AP3B1 STEAP2 SLC30A2 SLC10A7 EDNRA CCR2 NPTN SLC8A1 GRID2IP TMPRSS3 CCR5 CCR7 ATP12A ATP2B1 SLC37A4 SLC39A7 HYAL2 HTT | 3.61e-09 | 622 | 176 | 23 | GO:0098771 |
| GeneOntologyBiologicalProcess | cellular homeostasis | SLAMF8 CACNA1A HTR2B HTR2C TSPOAP1 GPR39 HMGCR GRM2 AP3B1 STEAP2 SLC30A2 SLC10A7 EDNRA DMXL1 CCR2 TYRO3 NPTN SLC8A1 ADRA2A ORMDL3 GRID2IP TMPRSS3 CCR5 CCR7 ATP12A ATP2B1 SLC37A4 SLC39A7 HTT | 4.62e-09 | 981 | 176 | 29 | GO:0019725 |
| GeneOntologyBiologicalProcess | chemical homeostasis | SLAMF8 CACNA1A HTR2B HTR2C TSPOAP1 GPR39 FFAR1 HMGCR GRM2 AP3B1 STEAP2 SLC30A2 SLC10A7 EDNRA DMXL1 CCR2 NPTN SLC8A1 ADRA1B ADRA2A ORMDL3 GRID2IP TMPRSS3 CCR5 CCR7 HAS2 ATP12A ATP2B1 SLC37A4 SLC39A7 HYAL2 DGAT1 HTT | 5.59e-09 | 1249 | 176 | 33 | GO:0048878 |
| GeneOntologyBiologicalProcess | monoatomic ion transport | CACNA1A TCAF2 TCAF1 RAMP1 HTR2B HTR2C SLC2A9 TSPOAP1 GPR39 FFAR1 ATP8B1 GRIN2C STEAP2 SLC30A2 SLC10A7 ATP10A SLC1A4 EDNRA CALHM4 CALHM2 ABCB1 CCR2 SLC8A1 ADRA2A SLC22A3 PKD1 TACR2 CCR5 CCR7 GRIN3B ATP12A ATP2B1 SLC39A7 HTT | 1.62e-08 | 1374 | 176 | 34 | GO:0006811 |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | CACNA1A TCAF2 TCAF1 HTR2B HTR2C SLC2A9 TSPOAP1 GPR39 FFAR1 ATP8B1 GRIN2C STEAP2 SLC30A2 ATP10A SLC1A4 EDNRA CALHM4 CALHM2 ABCB1 CCR2 SLC8A1 ADRA2A PKD1 CCR5 CCR7 GRIN3B ATP12A ATP2B1 SLC39A7 HTT | 2.06e-08 | 1115 | 176 | 30 | GO:0034220 |
| GeneOntologyBiologicalProcess | adenylate cyclase-modulating G protein-coupled receptor signaling pathway | RAMP1 S1PR2 GPR101 GRM2 EDNRA ADGRG7 ADRA1B ADRA2A ADRA2C ADGRG2 CCR3 RXFP1 ADGRL2 GPR119 ADGRD1 | 2.52e-08 | 286 | 176 | 15 | GO:0007188 |
| GeneOntologyBiologicalProcess | export from cell | CACNA1A HTR2C KALRN TSPOAP1 GPR39 FFAR1 APBA1 HMGCR ATP9A GRM2 STEAP2 SLC30A2 ABCB1 CCR2 TYRO3 SLC8A1 RAB3GAP1 ADRA2A ADRA2C STXBP2 BSG ARHGEF7 PKD1 TACR2 ATP12A ENG ATP2B1 GPR119 DGAT1 HTT | 4.34e-08 | 1153 | 176 | 30 | GO:0140352 |
| GeneOntologyBiologicalProcess | organic cation transport | CACNA1A HTR2C SLC7A7 SLC7A6 SLC1A4 ADRA2A ADRA2C SLC7A3 SLC22A3 TACR2 SLC25A17 | 4.80e-08 | 145 | 176 | 11 | GO:0015695 |
| GeneOntologyBiologicalProcess | intracellular calcium ion homeostasis | CACNA1A HTR2B HTR2C TSPOAP1 GPR39 SLC10A7 EDNRA CCR2 NPTN SLC8A1 GRID2IP CCR5 CCR7 ATP2B1 SLC37A4 HTT | 8.18e-08 | 359 | 176 | 16 | GO:0006874 |
| GeneOntologyBiologicalProcess | adenylate cyclase-activating G protein-coupled receptor signaling pathway | RAMP1 S1PR2 GPR101 ADGRG7 ADRA1B ADRA2A ADRA2C ADGRG2 RXFP1 ADGRL2 GPR119 ADGRD1 | 9.42e-08 | 191 | 176 | 12 | GO:0007189 |
| GeneOntologyBiologicalProcess | calcium ion homeostasis | CACNA1A HTR2B HTR2C TSPOAP1 GPR39 SLC10A7 EDNRA CCR2 NPTN SLC8A1 GRID2IP CCR5 CCR7 ATP2B1 SLC37A4 HTT | 2.43e-07 | 389 | 176 | 16 | GO:0055074 |
| GeneOntologyBiologicalProcess | calcium ion transmembrane transport | CACNA1A HTR2B HTR2C TSPOAP1 GPR39 FFAR1 GRIN2C EDNRA SLC8A1 ADRA2A PKD1 CCR5 CCR7 GRIN3B ATP2B1 HTT | 2.70e-07 | 392 | 176 | 16 | GO:0070588 |
| GeneOntologyBiologicalProcess | vascular process in circulatory system | HTR2B HTR2C HMGCR KLK3 SLC1A4 EDNRA ABCB1 SLC8A1 ADRA1B ADRA2A ADRA2C SLC7A3 SLC22A3 TACR2 ATP2B1 | 2.80e-07 | 344 | 176 | 15 | GO:0003018 |
| GeneOntologyBiologicalProcess | anterograde trans-synaptic signaling | CACNA1A HTR2B HTR2C TSPOAP1 APBA1 APBA2 S1PR2 HMGCR GRIN2C GRM2 SLC1A4 CALHM2 RIMBP3 CCR2 NPTN RAB3GAP1 ADRA2A GRID2IP STXBP2 RIMBP3C TACR2 GRIN3B RIMBP3B PCDH8 HTT | 3.73e-07 | 931 | 176 | 25 | GO:0098916 |
| GeneOntologyBiologicalProcess | chemical synaptic transmission | CACNA1A HTR2B HTR2C TSPOAP1 APBA1 APBA2 S1PR2 HMGCR GRIN2C GRM2 SLC1A4 CALHM2 RIMBP3 CCR2 NPTN RAB3GAP1 ADRA2A GRID2IP STXBP2 RIMBP3C TACR2 GRIN3B RIMBP3B PCDH8 HTT | 3.73e-07 | 931 | 176 | 25 | GO:0007268 |
| GeneOntologyBiologicalProcess | calcium ion transport | CACNA1A RAMP1 HTR2B HTR2C TSPOAP1 GPR39 FFAR1 GRIN2C EDNRA CALHM2 SLC8A1 ADRA2A PKD1 CCR5 CCR7 GRIN3B ATP2B1 HTT | 3.90e-07 | 509 | 176 | 18 | GO:0006816 |
| GeneOntologyBiologicalProcess | trans-synaptic signaling | CACNA1A HTR2B HTR2C TSPOAP1 APBA1 APBA2 S1PR2 HMGCR GRIN2C GRM2 SLC1A4 CALHM2 RIMBP3 CCR2 NPTN RAB3GAP1 ADRA2A GRID2IP STXBP2 RIMBP3C TACR2 GRIN3B RIMBP3B PCDH8 HTT | 4.37e-07 | 939 | 176 | 25 | GO:0099537 |
| GeneOntologyBiologicalProcess | positive regulation of cytosolic calcium ion concentration | CACNA1A FFAR1 CCRL2 EDNRA CCR2 NPTN SLC8A1 ADRA1B PKD1 CCR3 CCR5 CCR7 | 5.27e-07 | 224 | 176 | 12 | GO:0007204 |
| GeneOntologyBiologicalProcess | synaptic signaling | CACNA1A HTR2B HTR2C TSPOAP1 APBA1 APBA2 S1PR2 HMGCR GRIN2C GRM2 SLC1A4 CALHM2 RIMBP3 CCR2 NPTN RAB3GAP1 ADRA2A GRID2IP STXBP2 RIMBP3C TACR2 GRIN3B RIMBP3B PCDH8 HTT | 8.88e-07 | 976 | 176 | 25 | GO:0099536 |
| GeneOntologyBiologicalProcess | vasoconstriction | 9.73e-07 | 121 | 176 | 9 | GO:0042310 | |
| GeneOntologyBiologicalProcess | organophosphate ester transport | ATP8B1 ATP9A ATP10A CALHM2 ABCB1 EPG5 PRAP1 ATP11A SLC37A4 SLC25A17 | 1.34e-06 | 162 | 176 | 10 | GO:0015748 |
| GeneOntologyBiologicalProcess | organic anion transport | CACNA1A HTR2C SLC2A9 APBA1 ATP8B1 GRM2 SLC7A7 SLC7A6 SLC10A7 SLC1A4 CALHM2 ABCB1 RAB3GAP1 SLC7A3 SLC22A3 SLC37A4 SLC25A17 | 2.13e-06 | 515 | 176 | 17 | GO:0015711 |
| GeneOntologyBiologicalProcess | calcium ion transmembrane import into cytosol | CACNA1A HTR2B HTR2C GPR39 FFAR1 GRIN2C EDNRA SLC8A1 CCR5 CCR7 HTT | 2.72e-06 | 217 | 176 | 11 | GO:0097553 |
| GeneOntologyBiologicalProcess | modulation of chemical synaptic transmission | CACNA1A HTR2C TSPOAP1 APBA1 APBA2 S1PR2 HMGCR GRIN2C GRM2 CALHM2 CCR2 NPTN RAB3GAP1 ADRA2A GRID2IP TACR2 GRIN3B PCDH8 HTT | 4.16e-06 | 663 | 176 | 19 | GO:0050804 |
| GeneOntologyBiologicalProcess | regulation of trans-synaptic signaling | CACNA1A HTR2C TSPOAP1 APBA1 APBA2 S1PR2 HMGCR GRIN2C GRM2 CALHM2 CCR2 NPTN RAB3GAP1 ADRA2A GRID2IP TACR2 GRIN3B PCDH8 HTT | 4.26e-06 | 664 | 176 | 19 | GO:0099177 |
| GeneOntologyBiologicalProcess | monoatomic cation transmembrane transport | CACNA1A HTR2B HTR2C SLC2A9 TSPOAP1 GPR39 FFAR1 GRIN2C STEAP2 SLC30A2 EDNRA CALHM4 CALHM2 SLC8A1 ADRA2A PKD1 CCR5 CCR7 GRIN3B ATP12A ATP2B1 SLC39A7 HTT | 5.61e-06 | 942 | 176 | 23 | GO:0098655 |
| GeneOntologyBiologicalProcess | regulation of tube diameter | HTR2B HTR2C HMGCR KLK3 EDNRA SLC8A1 ADRA1B ADRA2A ADRA2C ATP2B1 | 9.62e-06 | 202 | 176 | 10 | GO:0035296 |
| GeneOntologyBiologicalProcess | blood vessel diameter maintenance | HTR2B HTR2C HMGCR KLK3 EDNRA SLC8A1 ADRA1B ADRA2A ADRA2C ATP2B1 | 9.62e-06 | 202 | 176 | 10 | GO:0097746 |
| GeneOntologyBiologicalProcess | regulation of tube size | HTR2B HTR2C HMGCR KLK3 EDNRA SLC8A1 ADRA1B ADRA2A ADRA2C ATP2B1 | 1.00e-05 | 203 | 176 | 10 | GO:0035150 |
| GeneOntologyBiologicalProcess | regulation of anion channel activity | 1.20e-05 | 6 | 176 | 3 | GO:0010359 | |
| GeneOntologyBiologicalProcess | carboxylic acid transport | CACNA1A HTR2C APBA1 ATP8B1 GRM2 SLC7A7 SLC7A6 SLC10A7 SLC1A4 ABCB1 RAB3GAP1 SLC7A3 SLC22A3 SLC25A17 | 1.20e-05 | 410 | 176 | 14 | GO:0046942 |
| GeneOntologyBiologicalProcess | organic acid transport | CACNA1A HTR2C APBA1 ATP8B1 GRM2 SLC7A7 SLC7A6 SLC10A7 SLC1A4 ABCB1 RAB3GAP1 SLC7A3 SLC22A3 SLC25A17 | 1.27e-05 | 412 | 176 | 14 | GO:0015849 |
| GeneOntologyBiologicalProcess | secretion by cell | CACNA1A HTR2C KALRN TSPOAP1 GPR39 FFAR1 APBA1 HMGCR ATP9A GRM2 STEAP2 CCR2 TYRO3 RAB3GAP1 ADRA2A ADRA2C STXBP2 BSG ARHGEF7 TACR2 ENG GPR119 DGAT1 HTT | 1.30e-05 | 1064 | 176 | 24 | GO:0032940 |
| GeneOntologyBiologicalProcess | neuromuscular synaptic transmission | 1.30e-05 | 36 | 176 | 5 | GO:0007274 | |
| GeneOntologyBiologicalProcess | regulation of monoatomic anion transport | 1.43e-05 | 18 | 176 | 4 | GO:0044070 | |
| GeneOntologyBiologicalProcess | metal ion transport | CACNA1A RAMP1 HTR2B HTR2C TSPOAP1 GPR39 FFAR1 GRIN2C STEAP2 SLC30A2 SLC10A7 EDNRA CALHM2 SLC8A1 ADRA2A PKD1 CCR5 CCR7 GRIN3B ATP12A ATP2B1 SLC39A7 HTT | 1.47e-05 | 1000 | 176 | 23 | GO:0030001 |
| GeneOntologyBiologicalProcess | monoatomic cation transport | CACNA1A RAMP1 HTR2B HTR2C SLC2A9 TSPOAP1 GPR39 FFAR1 GRIN2C STEAP2 SLC30A2 SLC10A7 EDNRA CALHM4 CALHM2 SLC8A1 ADRA2A PKD1 CCR5 CCR7 GRIN3B ATP12A ATP2B1 SLC39A7 HTT | 1.74e-05 | 1157 | 176 | 25 | GO:0006812 |
| GeneOntologyBiologicalProcess | smooth muscle contraction | 1.90e-05 | 133 | 176 | 8 | GO:0006939 | |
| GeneOntologyBiologicalProcess | inorganic ion transmembrane transport | CACNA1A HTR2B HTR2C SLC2A9 TSPOAP1 GPR39 FFAR1 GRIN2C STEAP2 SLC30A2 SLC1A4 EDNRA SLC8A1 ADRA2A PKD1 CCR5 CCR7 GRIN3B ATP12A ATP2B1 SLC37A4 SLC39A7 HTT | 1.92e-05 | 1017 | 176 | 23 | GO:0098660 |
| GeneOntologyBiologicalProcess | cytokine production | HTR2B FN1 BTNL8 FFAR1 FERMT1 PGLYRP3 AP3B1 IL18R1 EPG5 IFNAR1 IFNGR1 CCR2 NPTN ADRA2A CD226 BSG CCR5 CCR7 NMBR ACKR1 PRG4 ATP2B1 SLC37A4 HYAL2 | 1.96e-05 | 1091 | 176 | 24 | GO:0001816 |
| GeneOntologyBiologicalProcess | regulation of acetylcholine secretion, neurotransmission | 2.08e-05 | 7 | 176 | 3 | GO:0014056 | |
| GeneOntologyBiologicalProcess | acetylcholine secretion, neurotransmission | 2.08e-05 | 7 | 176 | 3 | GO:0014055 | |
| GeneOntologyBiologicalProcess | acetylcholine secretion | 3.31e-05 | 8 | 176 | 3 | GO:0061526 | |
| GeneOntologyBiologicalProcess | regulation of monoatomic anion transmembrane transport | 3.31e-05 | 8 | 176 | 3 | GO:1903959 | |
| GeneOntologyBiologicalProcess | release of sequestered calcium ion into cytosol | 3.71e-05 | 146 | 176 | 8 | GO:0051209 | |
| GeneOntologyBiologicalProcess | negative regulation of sequestering of calcium ion | 3.90e-05 | 147 | 176 | 8 | GO:0051283 | |
| GeneOntologyBiologicalProcess | inorganic cation transmembrane transport | CACNA1A HTR2B HTR2C SLC2A9 TSPOAP1 GPR39 FFAR1 GRIN2C STEAP2 SLC30A2 EDNRA SLC8A1 ADRA2A PKD1 CCR5 CCR7 GRIN3B ATP12A ATP2B1 SLC39A7 HTT | 4.11e-05 | 922 | 176 | 21 | GO:0098662 |
| GeneOntologyBiologicalProcess | secretion | CACNA1A HTR2C KALRN TSPOAP1 GPR39 FFAR1 APBA1 HMGCR ATP9A GRM2 STEAP2 EDNRA CCR2 TYRO3 RAB3GAP1 ADRA2A ADRA2C STXBP2 BSG ARHGEF7 TACR2 ENG GPR119 DGAT1 HTT | 4.25e-05 | 1221 | 176 | 25 | GO:0046903 |
| GeneOntologyBiologicalProcess | regulation of sequestering of calcium ion | 4.29e-05 | 149 | 176 | 8 | GO:0051282 | |
| GeneOntologyBiologicalProcess | signal release | CACNA1A HTR2C KALRN TSPOAP1 GPR39 FFAR1 HMGCR GRM2 RAB3GAP1 ADRA2A ADRA2C STXBP2 ARHGEF7 TACR2 GPR119 DGAT1 HTT | 4.62e-05 | 653 | 176 | 17 | GO:0023061 |
| GeneOntologyBiologicalProcess | amino acid transport | CACNA1A HTR2C APBA1 GRM2 SLC7A7 SLC7A6 SLC1A4 RAB3GAP1 SLC7A3 | 4.68e-05 | 195 | 176 | 9 | GO:0006865 |
| GeneOntologyBiologicalProcess | sequestering of calcium ion | 5.18e-05 | 153 | 176 | 8 | GO:0051208 | |
| GeneOntologyBiologicalProcess | regulation of cytokine production | HTR2B FN1 BTNL8 FFAR1 FERMT1 PGLYRP3 IL18R1 IFNAR1 IFNGR1 CCR2 NPTN ADRA2A CD226 BSG CCR5 CCR7 NMBR ACKR1 PRG4 ATP2B1 SLC37A4 HYAL2 | 5.19e-05 | 1010 | 176 | 22 | GO:0001817 |
| GeneOntologyBiologicalProcess | localization within membrane | CACNA1A TCAF2 TCAF1 RAMP1 MYO1C KALRN TM9SF1 GRIN2C ITGA3 ATP9A PLA2G4E AP3B1 STEAP2 ARHGEF16 EPG5 RAB3GAP1 BSG RAB3GAP2 GRIN3B | 5.44e-05 | 798 | 176 | 19 | GO:0051668 |
| GeneOntologyBiologicalProcess | adenylate cyclase-activating adrenergic receptor signaling pathway | 5.63e-05 | 25 | 176 | 4 | GO:0071880 | |
| GeneOntologyBiologicalProcess | cell chemotaxis | SLAMF8 CCRL2 ARHGEF16 STAP1 EDNRA CCR2 BSG CCR3 CCR5 CCR7 ENG SLC37A4 | 6.99e-05 | 363 | 176 | 12 | GO:0060326 |
| GeneOntologyBiologicalProcess | negative regulation of uterine smooth muscle contraction | 7.24e-05 | 2 | 176 | 2 | GO:0070473 | |
| GeneOntologyBiologicalProcess | regulation of anatomical structure size | HTR2B HTR2C FN1 MYO1C HMGCR KLK3 TTC3 EDNRA SLC8A1 ADRA1B ADRA2A ADRA2C CCR5 CCR7 MAP3K13 ATP2B1 | 8.30e-05 | 618 | 176 | 16 | GO:0090066 |
| GeneOntologyBiologicalProcess | calcium-mediated signaling | 9.98e-05 | 266 | 176 | 10 | GO:0019722 | |
| GeneOntologyBiologicalProcess | positive regulation of monoatomic ion transport | 9.98e-05 | 266 | 176 | 10 | GO:0043270 | |
| GeneOntologyBiologicalProcess | regulation of amine transport | 1.00e-04 | 125 | 176 | 7 | GO:0051952 | |
| GeneOntologyBiologicalProcess | dendritic cell chemotaxis | 1.03e-04 | 29 | 176 | 4 | GO:0002407 | |
| GeneOntologyBiologicalProcess | phospholipid translocation | 1.05e-04 | 55 | 176 | 5 | GO:0045332 | |
| GeneOntologyBiologicalProcess | regulation of phosphorylation | SLAMF8 HTR2B FN1 GPR39 S1PR2 TNFRSF18 HMGCR STAP1 EDNRA IFNAR1 TYRO3 NPTN SLC8A1 ADRA2A ADRA2C CSPG4 PTPRQ ROS1 CCR7 MAP3K13 ENG TNXB HYAL2 HTT | 1.23e-04 | 1226 | 176 | 24 | GO:0042325 |
| GeneOntologyBiologicalProcess | regulation of uterine smooth muscle contraction | 1.27e-04 | 12 | 176 | 3 | GO:0070472 | |
| GeneOntologyBiologicalProcess | acetylcholine transport | 1.27e-04 | 12 | 176 | 3 | GO:0015870 | |
| GeneOntologyBiologicalProcess | regulation of monoatomic ion transport | TCAF2 TCAF1 GPR39 FFAR1 ATP8B1 GRIN2C EDNRA ABCB1 CCR2 SLC8A1 ADRA2A TACR2 GRIN3B ATP2B1 HTT | 1.33e-04 | 577 | 176 | 15 | GO:0043269 |
| GeneOntologyBiologicalProcess | MAPK cascade | RCE1 HTR2B HTR2C FN1 GPR39 HMGCR GPR101 EDNRA CCR2 NPTN ADRA1B ADRA2A ADRA2C CSPG4 CCR3 ROS1 CCR7 MAP3K13 ARHGEF6 HYAL2 | 1.38e-04 | 930 | 176 | 20 | GO:0000165 |
| GeneOntologyBiologicalProcess | positive regulation of transport | TCAF1 HTR2C GPR39 FFAR1 PLA2G4E STAP1 EDNRA ABCB1 CCR2 RAB3GAP1 ADRA2A STXBP2 FCGR1A FCGR1BP BSG ARHGEF7 PRAP1 TACR2 CCR7 ATP2B1 HYAL2 HTT | 1.39e-04 | 1081 | 176 | 22 | GO:0051050 |
| GeneOntologyBiologicalProcess | synaptic transmission, glutamatergic | 1.41e-04 | 132 | 176 | 7 | GO:0035249 | |
| GeneOntologyBiologicalProcess | peptide hormone secretion | HTR2C KALRN GPR39 FFAR1 HMGCR ADRA2A ARHGEF7 TACR2 GPR119 DGAT1 HTT | 1.45e-04 | 334 | 176 | 11 | GO:0030072 |
| GeneOntologyBiologicalProcess | glutamate receptor signaling pathway | 1.47e-04 | 59 | 176 | 5 | GO:0007215 | |
| GeneOntologyBiologicalProcess | phospholipase C-activating G protein-coupled receptor signaling pathway | 1.47e-04 | 133 | 176 | 7 | GO:0007200 | |
| GeneOntologyBiologicalProcess | lipid translocation | 1.60e-04 | 60 | 176 | 5 | GO:0034204 | |
| GeneOntologyBiologicalProcess | uterine smooth muscle contraction | 1.64e-04 | 13 | 176 | 3 | GO:0070471 | |
| GeneOntologyBiologicalProcess | acetate ester transport | 1.64e-04 | 13 | 176 | 3 | GO:1901374 | |
| GeneOntologyBiologicalProcess | amine transport | 1.77e-04 | 137 | 176 | 7 | GO:0015837 | |
| GeneOntologyBiologicalProcess | peptide secretion | HTR2C KALRN GPR39 FFAR1 HMGCR ADRA2A ARHGEF7 TACR2 GPR119 DGAT1 HTT | 1.83e-04 | 343 | 176 | 11 | GO:0002790 |
| GeneOntologyBiologicalProcess | chemokine-mediated signaling pathway | 1.84e-04 | 97 | 176 | 6 | GO:0070098 | |
| GeneOntologyBiologicalProcess | regulation of vasoconstriction | 1.95e-04 | 98 | 176 | 6 | GO:0019229 | |
| GeneOntologyBiologicalProcess | regulation of secretion by cell | CACNA1A HTR2C KALRN TSPOAP1 GPR39 FFAR1 HMGCR ATP9A GRM2 CCR2 RAB3GAP1 ADRA2A ADRA2C STXBP2 BSG ARHGEF7 TACR2 | 2.09e-04 | 740 | 176 | 17 | GO:1903530 |
| GeneOntologyBiologicalProcess | phospholipase C-activating serotonin receptor signaling pathway | 2.16e-04 | 3 | 176 | 2 | GO:0007208 | |
| GeneOntologyBiologicalProcess | positive regulation of phosphatidylinositol biosynthetic process | 2.16e-04 | 3 | 176 | 2 | GO:0010513 | |
| GeneOntologyBiologicalProcess | establishment of protein localization to endoplasmic reticulum membrane | 2.16e-04 | 3 | 176 | 2 | GO:0097051 | |
| GeneOntologyBiologicalProcess | positive regulation of anion channel activity | 2.16e-04 | 3 | 176 | 2 | GO:1901529 | |
| GeneOntologyBiologicalProcess | positive regulation of anion transmembrane transport | 2.16e-04 | 3 | 176 | 2 | GO:1903961 | |
| GeneOntologyBiologicalProcess | adrenergic receptor signaling pathway | 2.18e-04 | 35 | 176 | 4 | GO:0071875 | |
| GeneOntologyBiologicalProcess | inflammatory response | SLAMF8 FN1 CCRL2 KLK3 AP3B1 IL18R1 STAP1 CALHM2 EPG5 STAB1 IFNGR1 CCR2 TYRO3 FCGR1A FCGR1BP FADS2 CCR3 CCR5 CCR7 ACKR1 HYAL2 | 2.30e-04 | 1043 | 176 | 21 | GO:0006954 |
| GeneOntologyBiologicalProcess | regulation of membrane lipid distribution | 2.33e-04 | 65 | 176 | 5 | GO:0097035 | |
| GeneOntologyBiologicalProcess | dendritic cell migration | 2.44e-04 | 36 | 176 | 4 | GO:0036336 | |
| GeneOntologyBiologicalProcess | peptide transport | HTR2C KALRN GPR39 FFAR1 HMGCR ADRA2A ARHGEF7 TACR2 GPR119 DGAT1 HTT | 2.46e-04 | 355 | 176 | 11 | GO:0015833 |
| GeneOntologyBiologicalProcess | L-arginine transmembrane transport | 2.58e-04 | 15 | 176 | 3 | GO:1903826 | |
| GeneOntologyBiologicalProcess | positive regulation of hypersensitivity | 2.58e-04 | 15 | 176 | 3 | GO:0002885 | |
| GeneOntologyBiologicalProcess | regulation of MAP kinase activity | 2.68e-04 | 194 | 176 | 8 | GO:0043405 | |
| GeneOntologyCellularComponent | cell surface | SLAMF8 RAMP1 HTR2C BTNL8 ITGA10 CCRL2 TNFRSF18 ITGA3 SLC1A4 ABCB1 CCR2 TYRO3 NPTN FCGR1A FCGR1BP ADGRG2 CD226 CSPG4 PVR PKD1 CD48 CCR3 ROS1 CCR5 CCR7 STRC ENG HYAL2 | 1.50e-07 | 1111 | 174 | 28 | GO:0009986 |
| GeneOntologyCellularComponent | external side of plasma membrane | HTR2C BTNL8 ITGA10 CCRL2 TNFRSF18 ITGA3 ABCB1 CCR2 FCGR1A FCGR1BP CD226 CD48 CCR3 CCR5 CCR7 ENG HYAL2 | 1.69e-06 | 519 | 174 | 17 | GO:0009897 |
| GeneOntologyCellularComponent | presynaptic active zone membrane | 3.94e-06 | 78 | 174 | 7 | GO:0048787 | |
| GeneOntologyCellularComponent | receptor complex | RAMP1 HTR2B HTR2C ITGA10 GPR84 GRIN2C ITGA3 GPR101 IL18R1 TYRO3 ADRA2A PTPRQ GPR156 ROS1 GRIN3B ENG GPR119 | 7.59e-06 | 581 | 174 | 17 | GO:0043235 |
| GeneOntologyCellularComponent | postsynaptic membrane | CACNA1A GRIN2C ITGA3 GRM2 NPTN SLC8A1 ADRA2A ADRA2C GRID2IP GPR156 GSG1L GRIN3B ADGRL2 PCDH8 | 7.91e-06 | 405 | 174 | 14 | GO:0045211 |
| GeneOntologyCellularComponent | synaptic membrane | CACNA1A APBA1 GRIN2C ITGA3 GRM2 NPTN SLC8A1 ADRA2A ADRA2C GRID2IP GPR156 GSG1L GRIN3B ADGRL2 ATP2B1 PCDH8 HTT | 7.94e-06 | 583 | 174 | 17 | GO:0097060 |
| GeneOntologyCellularComponent | basal plasma membrane | SLC2A9 MYO1C ITGA3 SLC7A7 SLC8A1 ADRA2A BSG SLC22A3 PTPRQ PKD1 ATP12A ATP2B1 SVOP | 8.87e-06 | 354 | 174 | 13 | GO:0009925 |
| GeneOntologyCellularComponent | basal part of cell | SLC2A9 MYO1C ITGA3 SLC7A7 SLC8A1 ADRA2A BSG SLC22A3 PTPRQ PKD1 ATP12A ATP2B1 SVOP | 1.78e-05 | 378 | 174 | 13 | GO:0045178 |
| GeneOntologyCellularComponent | IgM immunoglobulin complex, circulating | 3.08e-05 | 8 | 174 | 3 | GO:0071754 | |
| GeneOntologyCellularComponent | pentameric IgM immunoglobulin complex | 3.08e-05 | 8 | 174 | 3 | GO:0071756 | |
| GeneOntologyCellularComponent | postsynapse | CACNA1A KALRN APBA1 APBA2 S1PR2 GRIN2C ITGA3 GRM2 NPTN SLC8A1 RAB3GAP1 ADRA2A ADRA2C GRID2IP ARHGEF7 GPR156 GSG1L GRIN3B ADGRL2 ATP2B1 PCDH8 HTT | 4.01e-05 | 1018 | 174 | 22 | GO:0098794 |
| GeneOntologyCellularComponent | monomeric IgA immunoglobulin complex | 4.59e-05 | 9 | 174 | 3 | GO:0071748 | |
| GeneOntologyCellularComponent | polymeric IgA immunoglobulin complex | 6.52e-05 | 10 | 174 | 3 | GO:0071749 | |
| GeneOntologyCellularComponent | IgA immunoglobulin complex, circulating | 6.52e-05 | 10 | 174 | 3 | GO:0071746 | |
| GeneOntologyCellularComponent | secretory IgA immunoglobulin complex | 6.52e-05 | 10 | 174 | 3 | GO:0071751 | |
| GeneOntologyCellularComponent | presynapse | CACNA1A KALRN TSPOAP1 APBA1 APBA2 S1PR2 ITGA3 GRM2 NPTN SLC8A1 ADRA2A ADRA2C STXBP2 SLC22A3 GRIN3B ATP2B1 SVOP PCDH8 HTT | 1.54e-04 | 886 | 174 | 19 | GO:0098793 |
| GeneOntologyCellularComponent | presynaptic active zone | 1.82e-04 | 141 | 174 | 7 | GO:0048786 | |
| GeneOntologyCellularComponent | phospholipid-translocating ATPase complex | 1.93e-04 | 14 | 174 | 3 | GO:1990531 | |
| GeneOntologyCellularComponent | IgA immunoglobulin complex | 2.40e-04 | 15 | 174 | 3 | GO:0071745 | |
| GeneOntologyCellularComponent | IgM immunoglobulin complex | 2.40e-04 | 15 | 174 | 3 | GO:0071753 | |
| GeneOntologyCellularComponent | nuclear outer membrane-endoplasmic reticulum membrane network | RCE1 PIGN UGT2A2 HMGCR GRIN2C SLC10A7 ATP10A TYRO3 RAB3GAP1 CEPT1 ORMDL3 BSG SLC22A3 RAB3GAP2 DHCR24 TMPRSS3 PEDS1 FADS2 ATP11A HAS2 GRIN3B SLC37A4 SLC39A7 DGAT1 | 2.75e-04 | 1327 | 174 | 24 | GO:0042175 |
| GeneOntologyCellularComponent | immunoglobulin complex, circulating | 3.54e-04 | 17 | 174 | 3 | GO:0042571 | |
| GeneOntologyCellularComponent | basolateral plasma membrane | SLC2A9 ITGA3 SLC7A7 SLC8A1 ADRA2A BSG SLC22A3 PKD1 ATP12A ATP2B1 | 3.62e-04 | 320 | 174 | 10 | GO:0016323 |
| GeneOntologyCellularComponent | side of membrane | HTR2C BTNL8 ITGA10 CCRL2 TNFRSF18 ITGA3 ABCB1 CCR2 FCGR1A FCGR1BP CD226 CD48 CCR3 CCR5 CCR7 ENG ATP2B1 HYAL2 | 3.81e-04 | 875 | 174 | 18 | GO:0098552 |
| GeneOntologyCellularComponent | G protein-coupled serotonin receptor complex | 4.09e-04 | 4 | 174 | 2 | GO:0098666 | |
| GeneOntologyCellularComponent | endoplasmic reticulum membrane | RCE1 PIGN UGT2A2 HMGCR GRIN2C SLC10A7 ATP10A TYRO3 RAB3GAP1 CEPT1 ORMDL3 BSG RAB3GAP2 DHCR24 TMPRSS3 PEDS1 FADS2 ATP11A HAS2 GRIN3B SLC37A4 SLC39A7 DGAT1 | 4.69e-04 | 1293 | 174 | 23 | GO:0005789 |
| GeneOntologyCellularComponent | glutamatergic synapse | CACNA1A KALRN TSPOAP1 APBA1 S1PR2 GRIN2C ITGA3 GRM2 NPTN ADRA2A ADRA2C GRID2IP GSG1L ADGRL2 ATP2B1 PCDH8 HTT | 4.89e-04 | 817 | 174 | 17 | GO:0098978 |
| GeneOntologyCellularComponent | endoplasmic reticulum subcompartment | RCE1 PIGN UGT2A2 HMGCR GRIN2C SLC10A7 ATP10A TYRO3 RAB3GAP1 CEPT1 ORMDL3 BSG RAB3GAP2 DHCR24 TMPRSS3 PEDS1 FADS2 ATP11A HAS2 GRIN3B SLC37A4 SLC39A7 DGAT1 | 5.00e-04 | 1299 | 174 | 23 | GO:0098827 |
| GeneOntologyCellularComponent | presynaptic membrane | 5.39e-04 | 277 | 174 | 9 | GO:0042734 | |
| GeneOntologyCellularComponent | somatodendritic compartment | CACNA1A HTR2B HTR2C KALRN FAT3 APBA1 APBA2 GRM2 SLC1A4 IFNGR1 CCR2 NPTN SLC8A1 ADRA2A ADRA2C ARHGEF7 SLC22A3 TMPRSS3 GRIN3B ATP2B1 PCDH8 HTT | 5.71e-04 | 1228 | 174 | 22 | GO:0036477 |
| GeneOntologyCellularComponent | apical plasma membrane | SLC2A9 FN1 ATP8B1 ABCB1 STXBP2 ADGRG2 SLC22A3 CSPG4 PTPRQ ATP12A ATP2B1 HYAL2 | 8.09e-04 | 487 | 174 | 12 | GO:0016324 |
| GeneOntologyCellularComponent | specific granule membrane | 9.85e-04 | 91 | 174 | 5 | GO:0035579 | |
| GeneOntologyCellularComponent | apical part of cell | SLC2A9 FN1 ATP8B1 KLK3 ABCB1 STXBP2 ADGRG2 SLC22A3 CSPG4 PTPRQ ATP12A ATP2B1 HYAL2 | 1.41e-03 | 592 | 174 | 13 | GO:0045177 |
| GeneOntologyCellularComponent | manchette | 1.59e-03 | 28 | 174 | 3 | GO:0002177 | |
| GeneOntologyCellularComponent | postsynaptic density membrane | 2.05e-03 | 157 | 174 | 6 | GO:0098839 | |
| GeneOntologyCellularComponent | specific granule | 2.25e-03 | 160 | 174 | 6 | GO:0042581 | |
| GeneOntologyCellularComponent | NMDA selective glutamate receptor complex | 2.39e-03 | 9 | 174 | 2 | GO:0017146 | |
| GeneOntologyCellularComponent | stereocilium | 2.63e-03 | 69 | 174 | 4 | GO:0032420 | |
| GeneOntologyCellularComponent | cytoplasmic vesicle membrane | MON2 MYO1C UBR4 GPR84 ATP9A PLA2G4E AP3B1 STEAP2 SLC30A2 STAB1 ORMDL3 STXBP2 FCGR1A FCGR1BP BSG PKD1 ATP11A ATP2B1 SVOP DGAT1 HTT | 2.91e-03 | 1307 | 174 | 21 | GO:0030659 |
| GeneOntologyCellularComponent | vesicle membrane | MON2 MYO1C UBR4 GPR84 ATP9A PLA2G4E AP3B1 STEAP2 SLC30A2 STAB1 ORMDL3 STXBP2 FCGR1A FCGR1BP BSG PKD1 ATP11A ATP2B1 SVOP DGAT1 HTT | 3.41e-03 | 1325 | 174 | 21 | GO:0012506 |
| GeneOntologyCellularComponent | G protein-coupled receptor complex | 3.61e-03 | 11 | 174 | 2 | GO:0097648 | |
| GeneOntologyCellularComponent | endosome | MON2 UBR4 FYCO1 ATP9A PLA2G4E AP3B1 STEAP2 SLC30A2 IFNAR1 ADRA2C FCGR1A FCGR1BP BSG OSBPL1A CCR3 CCR5 ATP11A ACKR1 HTT | 3.99e-03 | 1167 | 174 | 19 | GO:0005768 |
| GeneOntologyCellularComponent | vacuole | TM9SF1 FYCO1 PLA2G4E AP3B1 TTC3 SLC30A2 EPG5 IFNAR1 STXBP2 ARHGEF7 CSPG4 ATP11A HAS2 CTSO HYAL2 HTT | 4.07e-03 | 913 | 174 | 16 | GO:0005773 |
| GeneOntologyCellularComponent | stereocilium bundle | 4.29e-03 | 79 | 174 | 4 | GO:0032421 | |
| GeneOntologyCellularComponent | dendrite | CACNA1A HTR2B HTR2C FAT3 APBA1 APBA2 GRM2 SLC1A4 IFNGR1 CCR2 NPTN SLC8A1 ATP2B1 PCDH8 HTT | 5.49e-03 | 858 | 174 | 15 | GO:0030425 |
| GeneOntologyCellularComponent | dendritic tree | CACNA1A HTR2B HTR2C FAT3 APBA1 APBA2 GRM2 SLC1A4 IFNGR1 CCR2 NPTN SLC8A1 ATP2B1 PCDH8 HTT | 5.60e-03 | 860 | 174 | 15 | GO:0097447 |
| GeneOntologyCellularComponent | secretory granule membrane | 6.44e-03 | 329 | 174 | 8 | GO:0030667 | |
| GeneOntologyCellularComponent | postsynaptic specialization membrane | 6.83e-03 | 201 | 174 | 6 | GO:0099634 | |
| HumanPheno | Abnormal glomerular filtration rate | 9.89e-06 | 29 | 53 | 5 | HP:0012212 | |
| HumanPheno | Decreased glomerular filtration rate | 9.89e-06 | 29 | 53 | 5 | HP:0012213 | |
| Domain | GPCR_Rhodpsn_7TM | HTR2B HTR2C GPR39 FFAR1 GPR84 CCRL2 S1PR2 TAAR8 GPR101 EDNRA CCR2 ADRA1B OR10AG1 ADRA2A ADRA2C OR5AC2 OR51I1 OR51B6 OR6C75 CCR3 TACR2 CCR5 CCR7 RXFP1 NMBR OR52B2 GPR119 OR2H2 | 9.17e-12 | 670 | 167 | 28 | IPR017452 |
| Domain | 7tm_1 | HTR2B HTR2C GPR39 FFAR1 GPR84 CCRL2 S1PR2 TAAR8 GPR101 EDNRA CCR2 ADRA1B OR10AG1 ADRA2A ADRA2C OR5AC2 OR51I1 OR51B6 OR6C75 CCR3 TACR2 CCR5 CCR7 RXFP1 NMBR OR52B2 GPR119 OR2H2 | 1.17e-11 | 677 | 167 | 28 | PF00001 |
| Domain | G_PROTEIN_RECEP_F1_1 | HTR2B HTR2C GPR39 FFAR1 GPR84 CCRL2 S1PR2 TAAR8 GPR101 EDNRA CCR2 ADRA1B OR10AG1 ADRA2A ADRA2C OR5AC2 OR51I1 OR51B6 OR6C75 CCR3 TACR2 CCR5 CCR7 RXFP1 NMBR OR52B2 GPR119 OR2H2 | 1.54e-11 | 685 | 167 | 28 | PS00237 |
| Domain | G_PROTEIN_RECEP_F1_2 | HTR2B HTR2C GPR39 FFAR1 GPR84 CCRL2 S1PR2 TAAR8 GPR101 EDNRA CCR2 ADRA1B OR10AG1 ADRA2A ADRA2C OR5AC2 OR51I1 OR51B6 OR6C75 CCR3 TACR2 CCR5 CCR7 RXFP1 NMBR OR52B2 GPR119 OR2H2 | 1.90e-11 | 691 | 167 | 28 | PS50262 |
| Domain | GPCR_Rhodpsn | HTR2B HTR2C GPR39 FFAR1 GPR84 CCRL2 S1PR2 TAAR8 GPR101 EDNRA CCR2 ADRA1B OR10AG1 ADRA2A ADRA2C OR5AC2 OR51I1 OR51B6 OR6C75 CCR3 TACR2 CCR5 CCR7 RXFP1 NMBR OR52B2 GPR119 OR2H2 | 1.96e-11 | 692 | 167 | 28 | IPR000276 |
| Domain | 7TM_GPCR_Srsx | HTR2B HTR2C S1PR2 TAAR8 CCR2 ADRA1B ADRA2A ADRA2C OR51I1 TACR2 NMBR | 5.05e-09 | 112 | 167 | 11 | SM01381 |
| Domain | Chemokine_rcpt | 2.17e-07 | 16 | 167 | 5 | IPR000355 | |
| Domain | - | 3.49e-07 | 32 | 167 | 6 | 3.40.1110.10 | |
| Domain | - | 3.49e-07 | 32 | 167 | 6 | 2.70.150.10 | |
| Domain | ATPase_P-typ_cyto_domN | 6.12e-07 | 35 | 167 | 6 | IPR023299 | |
| Domain | ATPase_P-typ_P_site | 7.28e-07 | 36 | 167 | 6 | IPR018303 | |
| Domain | P_typ_ATPase | 7.28e-07 | 36 | 167 | 6 | IPR001757 | |
| Domain | ATPASE_E1_E2 | 7.28e-07 | 36 | 167 | 6 | PS00154 | |
| Domain | ATPase_P-typ_transduc_dom_A | 8.63e-07 | 37 | 167 | 6 | IPR008250 | |
| Domain | E1-E2_ATPase | 8.63e-07 | 37 | 167 | 6 | PF00122 | |
| Domain | Ig-like_fold | SLAMF8 FN1 KALRN BTNL8 TSPOAP1 IL18R1 IFNAR1 RIMBP3 IFNGR1 TYRO3 NPTN FCGR1A FCGR1BP CD226 BSG PVR CD48 RIMBP3C ROS1 RIMBP3B TNXB | 1.40e-06 | 706 | 167 | 21 | IPR013783 |
| Domain | - | FN1 KALRN BTNL8 TSPOAP1 IL18R1 IFNAR1 RIMBP3 IFNGR1 TYRO3 NPTN FCGR1A FCGR1BP CD226 BSG PVR CD48 RIMBP3C ROS1 RIMBP3B TNXB | 2.05e-06 | 663 | 167 | 20 | 2.60.40.10 |
| Domain | FN3_dom | FN1 KALRN TSPOAP1 IFNAR1 RIMBP3 IFNGR1 TYRO3 RIMBP3C ROS1 RIMBP3B TNXB | 2.91e-06 | 209 | 167 | 11 | IPR003961 |
| Domain | P_typ_ATPase_c | 5.76e-06 | 14 | 167 | 4 | IPR032630 | |
| Domain | P-type_ATPase_N | 5.76e-06 | 14 | 167 | 4 | IPR032631 | |
| Domain | P-type_ATPase_IV | 5.76e-06 | 14 | 167 | 4 | IPR006539 | |
| Domain | PhoLip_ATPase_C | 5.76e-06 | 14 | 167 | 4 | PF16212 | |
| Domain | PhoLip_ATPase_N | 5.76e-06 | 14 | 167 | 4 | PF16209 | |
| Domain | GPS | 1.21e-05 | 34 | 167 | 5 | SM00303 | |
| Domain | FN3 | FN1 KALRN TSPOAP1 IFNAR1 RIMBP3 TYRO3 RIMBP3C ROS1 RIMBP3B TNXB | 1.25e-05 | 199 | 167 | 10 | PS50853 |
| Domain | GPS | 1.41e-05 | 35 | 167 | 5 | PF01825 | |
| Domain | GPS | 1.62e-05 | 36 | 167 | 5 | PS50221 | |
| Domain | GPS | 1.86e-05 | 37 | 167 | 5 | IPR000203 | |
| Domain | FN3 | 4.41e-05 | 185 | 167 | 9 | SM00060 | |
| Domain | MFS | 5.27e-05 | 108 | 167 | 7 | PS50850 | |
| Domain | SH3_9 | 7.05e-05 | 78 | 167 | 6 | PF14604 | |
| Domain | HAD-like_dom | 7.57e-05 | 79 | 167 | 6 | IPR023214 | |
| Domain | Basigin | 7.95e-05 | 2 | 167 | 2 | IPR009151 | |
| Domain | M60-like | 7.95e-05 | 2 | 167 | 2 | SM01276 | |
| Domain | Peptidase_M60_dom | 7.95e-05 | 2 | 167 | 2 | IPR031161 | |
| Domain | Peptidase_M60 | 7.95e-05 | 2 | 167 | 2 | PF13402 | |
| Domain | Chemokine_CCR5 | 7.95e-05 | 2 | 167 | 2 | IPR002240 | |
| Domain | PEPTIDASE_M60 | 7.95e-05 | 2 | 167 | 2 | PS51723 | |
| Domain | ADR_fam | 8.05e-05 | 10 | 167 | 3 | IPR002233 | |
| Domain | SH3_2 | 1.22e-04 | 86 | 167 | 6 | PF07653 | |
| Domain | SH3_2 | 1.22e-04 | 86 | 167 | 6 | IPR011511 | |
| Domain | AA_permease_2 | 1.88e-04 | 13 | 167 | 3 | PF13520 | |
| Domain | AA/rel_permease1 | 1.88e-04 | 13 | 167 | 3 | IPR002293 | |
| Domain | MFS_dom | 2.04e-04 | 134 | 167 | 7 | IPR020846 | |
| Domain | GSG-1 | 2.37e-04 | 3 | 167 | 2 | PF07803 | |
| Domain | GSG-1 | 2.37e-04 | 3 | 167 | 2 | IPR012478 | |
| Domain | SUGAR_TRANSPORT_2 | 4.35e-04 | 17 | 167 | 3 | PS00217 | |
| Domain | SH3 | KALRN TSPOAP1 ARHGEF16 RIMBP3 ARHGEF7 RIMBP3C RIMBP3B ARHGEF6 | 7.39e-04 | 216 | 167 | 8 | SM00326 |
| Domain | SH3 | KALRN TSPOAP1 ARHGEF16 RIMBP3 ARHGEF7 RIMBP3C RIMBP3B ARHGEF6 | 7.39e-04 | 216 | 167 | 8 | PS50002 |
| Domain | SH3_domain | KALRN TSPOAP1 ARHGEF16 RIMBP3 ARHGEF7 RIMBP3C RIMBP3B ARHGEF6 | 8.33e-04 | 220 | 167 | 8 | IPR001452 |
| Domain | AA-permease/SLC12A_dom | 9.54e-04 | 22 | 167 | 3 | IPR004841 | |
| Domain | AA_permease | 9.54e-04 | 22 | 167 | 3 | PF00324 | |
| Domain | 7tm_2 | 1.03e-03 | 50 | 167 | 4 | PF00002 | |
| Domain | G_PROTEIN_RECEP_F2_2 | 1.03e-03 | 50 | 167 | 4 | PS00650 | |
| Domain | Ca_hom_mod | 1.16e-03 | 6 | 167 | 2 | PF14798 | |
| Domain | FAM26 | 1.16e-03 | 6 | 167 | 2 | IPR029569 | |
| Domain | SUGAR_TRANSPORT_1 | 1.24e-03 | 24 | 167 | 3 | PS00216 | |
| Domain | IG | KALRN BTNL8 IL18R1 TYRO3 NPTN FCGR1A FCGR1BP CD226 BSG PVR CD48 | 1.46e-03 | 421 | 167 | 11 | SM00409 |
| Domain | Ig_sub | KALRN BTNL8 IL18R1 TYRO3 NPTN FCGR1A FCGR1BP CD226 BSG PVR CD48 | 1.46e-03 | 421 | 167 | 11 | IPR003599 |
| Domain | IG_LIKE | SLAMF8 KALRN BTNL8 IL18R1 TYRO3 NPTN FCGR1A FCGR1BP CD226 BSG PVR CD48 | 1.58e-03 | 491 | 167 | 12 | PS50835 |
| Domain | Ig-like_dom | SLAMF8 KALRN BTNL8 IL18R1 TYRO3 NPTN FCGR1A FCGR1BP CD226 BSG PVR CD48 | 1.93e-03 | 503 | 167 | 12 | IPR007110 |
| Domain | GPCR_2_secretin-like | 2.04e-03 | 60 | 167 | 4 | IPR000832 | |
| Domain | GPCR_2-like | 2.04e-03 | 60 | 167 | 4 | IPR017981 | |
| Domain | G_PROTEIN_RECEP_F2_4 | 2.16e-03 | 61 | 167 | 4 | PS50261 | |
| Domain | DH_1 | 2.44e-03 | 63 | 167 | 4 | PS00741 | |
| Domain | - | 2.58e-03 | 64 | 167 | 4 | 3.40.50.1000 | |
| Domain | Orgcat_transp/SVOP | 2.75e-03 | 9 | 167 | 2 | IPR004749 | |
| Domain | 5HT_rcpt | 2.75e-03 | 9 | 167 | 2 | IPR002231 | |
| Domain | Sugar_transporter_CS | 2.88e-03 | 32 | 167 | 3 | IPR005829 | |
| Domain | RhoGEF | 3.22e-03 | 68 | 167 | 4 | SM00325 | |
| Domain | fn3 | 3.39e-03 | 162 | 167 | 6 | PF00041 | |
| Domain | GPCR_2_secretin-like_CS | 3.43e-03 | 34 | 167 | 3 | IPR017983 | |
| Domain | RhoGEF | 3.57e-03 | 70 | 167 | 4 | PF00621 | |
| Domain | DH_2 | 3.57e-03 | 70 | 167 | 4 | PS50010 | |
| Domain | - | 3.76e-03 | 71 | 167 | 4 | 1.20.900.10 | |
| Domain | DH-domain | 3.76e-03 | 71 | 167 | 4 | IPR000219 | |
| Domain | MFS_sugar_transport-like | 4.04e-03 | 36 | 167 | 3 | IPR005828 | |
| Domain | Sugar_tr | 4.04e-03 | 36 | 167 | 3 | PF00083 | |
| Domain | Class_I_gatase-like | 4.95e-03 | 12 | 167 | 2 | IPR029062 | |
| Domain | Tissue_fac | 4.95e-03 | 12 | 167 | 2 | PF01108 | |
| Domain | Tissue_factor | 4.95e-03 | 12 | 167 | 2 | IPR001187 | |
| Domain | MFS_1 | 5.03e-03 | 77 | 167 | 4 | PF07690 | |
| Domain | MFS | 5.03e-03 | 77 | 167 | 4 | IPR011701 | |
| Domain | Peripla_BP_I | 5.07e-03 | 39 | 167 | 3 | IPR028082 | |
| Domain | GDS_CDC24_CS | 5.07e-03 | 39 | 167 | 3 | IPR001331 | |
| Domain | IGc2 | 5.28e-03 | 235 | 167 | 7 | SM00408 | |
| Domain | Ig_sub2 | 5.28e-03 | 235 | 167 | 7 | IPR003598 | |
| Domain | Sugar/inositol_transpt | 6.74e-03 | 14 | 167 | 2 | IPR003663 | |
| Domain | ig | 7.31e-03 | 190 | 167 | 6 | PF00047 | |
| Domain | Immunoglobulin | 7.31e-03 | 190 | 167 | 6 | IPR013151 | |
| Domain | - | KALRN FERMT1 APBA1 APBA2 ARHGEF16 STAP1 ARHGEF7 OSBPL1A ARHGEF6 | 8.71e-03 | 391 | 167 | 9 | 2.30.29.30 |
| Domain | ATPase_P-typ_TM_dom | 8.78e-03 | 16 | 167 | 2 | IPR023298 | |
| Domain | - | 8.78e-03 | 16 | 167 | 2 | 1.20.1110.10 | |
| Pathway | WP_GPCRS_NONODORANT | HTR2B HTR2C FFAR1 CCRL2 S1PR2 GRM2 EDNRA CCR2 ADRA1B ADRA2A ADRA2C ADGRG2 CCR3 TACR2 CCR7 RXFP1 NMBR ADGRL2 ACKR1 GPR119 | 1.76e-12 | 266 | 140 | 20 | MM15843 |
| Pathway | REACTOME_SIGNALING_BY_GPCR | RAMP1 HTR2B HTR2C FN1 CAMKK1 KALRN GPR39 FFAR1 GPR84 CCRL2 S1PR2 TAAR8 GRM2 ARHGEF16 EDNRA CCR2 ADRA1B ADRA2A ADRA2C ARHGEF7 CCR3 TACR2 CCR5 CCR7 RXFP1 NMBR ACKR1 ARHGEF6 | 2.20e-10 | 702 | 140 | 28 | M746 |
| Pathway | REACTOME_CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS | HTR2B HTR2C GPR39 FFAR1 CCRL2 S1PR2 TAAR8 EDNRA CCR2 ADRA1B ADRA2A ADRA2C CCR3 TACR2 CCR5 CCR7 RXFP1 NMBR ACKR1 | 6.53e-10 | 330 | 140 | 19 | M18334 |
| Pathway | REACTOME_SIGNALING_BY_GPCR | RAMP1 HTR2B HTR2C FN1 CAMKK1 KALRN GPR39 FFAR1 GPR84 CCRL2 S1PR2 TAAR8 GRM2 ARHGEF16 EDNRA ADRA1B ADRA2A ADRA2C ARHGEF7 CCR3 TACR2 CCR5 CCR7 RXFP1 NMBR ARHGEF6 | 8.89e-10 | 646 | 140 | 26 | MM14962 |
| Pathway | REACTOME_GPCR_LIGAND_BINDING | RAMP1 HTR2B HTR2C GPR39 FFAR1 CCRL2 S1PR2 TAAR8 GRM2 EDNRA CCR2 ADRA1B ADRA2A ADRA2C CCR3 TACR2 CCR5 CCR7 RXFP1 NMBR ACKR1 | 5.68e-09 | 463 | 140 | 21 | M507 |
| Pathway | REACTOME_CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS | HTR2B HTR2C GPR39 FFAR1 CCRL2 S1PR2 TAAR8 EDNRA ADRA1B ADRA2A ADRA2C CCR3 TACR2 CCR5 CCR7 RXFP1 NMBR | 3.31e-08 | 333 | 140 | 17 | MM14963 |
| Pathway | WP_GPCRS_CLASS_A_RHODOPSINLIKE | HTR2B HTR2C GPR39 FFAR1 CCRL2 EDNRA CCR2 ADRA1B ADRA2A ADRA2C CCR3 CCR5 CCR7 NMBR OR2H2 | 4.54e-08 | 260 | 140 | 15 | M39397 |
| Pathway | REACTOME_GPCR_LIGAND_BINDING | RAMP1 HTR2B HTR2C GPR39 FFAR1 CCRL2 S1PR2 TAAR8 GRM2 EDNRA ADRA1B ADRA2A ADRA2C CCR3 TACR2 CCR5 CCR7 RXFP1 NMBR | 4.91e-08 | 430 | 140 | 19 | MM15160 |
| Pathway | KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION | HTR2B HTR2C S1PR2 GRIN2C TAAR8 GRM2 EDNRA ADRA1B ADRA2A ADRA2C GPR156 TACR2 RXFP1 GRIN3B NMBR | 8.23e-08 | 272 | 140 | 15 | M13380 |
| Pathway | WP_SELECTIVE_EXPRESSION_OF_CHEMOKINE_RECEPTORS_DURING_TCELL_POLARIZATION | 3.39e-07 | 29 | 140 | 6 | M39797 | |
| Pathway | BIOCARTA_NKT_PATHWAY | 6.31e-07 | 32 | 140 | 6 | MM1492 | |
| Pathway | WP_PEPTIDE_GPCRS | 7.46e-07 | 75 | 140 | 8 | M39696 | |
| Pathway | REACTOME_AMINE_LIGAND_BINDING_RECEPTORS | 3.37e-06 | 42 | 140 | 6 | M5868 | |
| Pathway | REACTOME_AMINE_LIGAND_BINDING_RECEPTORS | 3.37e-06 | 42 | 140 | 6 | MM14971 | |
| Pathway | WP_GPCRS_OTHER | 3.87e-06 | 93 | 140 | 8 | M39629 | |
| Pathway | BIOCARTA_NKT_PATHWAY | 5.00e-06 | 26 | 140 | 5 | M4047 | |
| Pathway | WP_GPCRS_PEPTIDE | 5.83e-06 | 70 | 140 | 7 | MM15959 | |
| Pathway | WP_MONOAMINE_GPCRS | 1.24e-05 | 31 | 140 | 5 | MM15871 | |
| Pathway | WP_GPCRS_CLASS_A_RHODOPSINLIKE | 1.64e-05 | 186 | 140 | 10 | MM15994 | |
| Pathway | REACTOME_ION_TRANSPORT_BY_P_TYPE_ATPASES | 1.67e-05 | 55 | 140 | 6 | M971 | |
| Pathway | WP_MONOAMINE_GPCRS | 1.71e-05 | 33 | 140 | 5 | M39585 | |
| Pathway | REACTOME_ION_TRANSPORT_BY_P_TYPE_ATPASES | 2.06e-05 | 57 | 140 | 6 | MM15643 | |
| Pathway | REACTOME_CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL | FN1 IGHV2-70 ITGA3 SLC7A7 SLC7A6 BSG CD48 IGKV3D-20 IGKV3-20 IGKV3-11 | 2.35e-05 | 194 | 140 | 10 | M16312 |
| Pathway | REACTOME_PEPTIDE_LIGAND_BINDING_RECEPTORS | 2.69e-05 | 197 | 140 | 10 | M12289 | |
| Pathway | REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT | SLC2A9 SLC7A7 SLC7A6 SLC30A2 SLC1A4 SLC8A1 SLC7A3 BSG SLC22A3 SLC2A12 SLC39A7 | 3.82e-05 | 249 | 140 | 11 | M5988 |
| Pathway | KEGG_CALCIUM_SIGNALING_PATHWAY | 7.07e-05 | 178 | 140 | 9 | M2890 | |
| Pathway | REACTOME_ADRENOCEPTORS | 7.71e-05 | 9 | 140 | 3 | M27302 | |
| Pathway | REACTOME_ADRENOCEPTORS | 7.71e-05 | 9 | 140 | 3 | MM15009 | |
| Pathway | REACTOME_BASIGIN_INTERACTIONS | 8.48e-05 | 24 | 140 | 4 | MM17215 | |
| Pathway | REACTOME_BASIGIN_INTERACTIONS | 1.00e-04 | 25 | 140 | 4 | M4974 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ITGA_B_FAK_CDC42_SIGNALING_PATHWAY | 1.18e-04 | 26 | 140 | 4 | M47719 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | SLC2A9 ATP8B1 ATP9A SLC7A7 SLC7A6 SLC30A2 ATP10A SLC1A4 ABCB1 SLC8A1 SLC7A3 BSG SLC22A3 ATP11A ATP12A SLC2A12 ATP2B1 UNC79 SLC39A7 | 1.22e-04 | 736 | 140 | 19 | M27287 |
| Pathway | REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT | SLC2A9 SLC7A7 SLC7A6 SLC1A4 SLC8A1 SLC7A3 BSG SLC22A3 SLC2A12 SLC39A7 | 1.31e-04 | 238 | 140 | 10 | MM15076 |
| Pathway | KEGG_MEDICUS_REFERENCE_GPCR_PLCB_ITPR_SIGNALING_PATHWAY | 1.33e-04 | 50 | 140 | 5 | M47951 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | SLC2A9 ATP8B1 ATP9A SLC7A7 SLC7A6 ATP10A SLC1A4 ABCB1 SLC8A1 SLC7A3 BSG SLC22A3 ATP11A ATP12A SLC2A12 ATP2B1 UNC79 SLC39A7 | 1.39e-04 | 681 | 140 | 18 | MM14985 |
| Pathway | REACTOME_G_ALPHA_Q_SIGNALLING_EVENTS | 2.47e-04 | 210 | 140 | 9 | MM15043 | |
| Pathway | REACTOME_CHEMOKINE_RECEPTORS_BIND_CHEMOKINES | 2.49e-04 | 57 | 140 | 5 | M625 | |
| Pathway | REACTOME_AMINO_ACID_TRANSPORT_ACROSS_THE_PLASMA_MEMBRANE | 2.70e-04 | 32 | 140 | 4 | MM14957 | |
| Pathway | REACTOME_AMINO_ACID_TRANSPORT_ACROSS_THE_PLASMA_MEMBRANE | 3.05e-04 | 33 | 140 | 4 | M188 | |
| Pathway | REACTOME_G_ALPHA_Q_SIGNALLING_EVENTS | 3.15e-04 | 217 | 140 | 9 | M18437 | |
| Pathway | WP_GPCRS_OTHER | 3.84e-04 | 96 | 140 | 6 | MM15939 | |
| Pathway | REACTOME_FCGR_ACTIVATION | 6.07e-04 | 69 | 140 | 5 | M27108 | |
| Pathway | REACTOME_PEPTIDE_LIGAND_BINDING_RECEPTORS | 7.82e-04 | 197 | 140 | 8 | MM14970 | |
| Pathway | REACTOME_ABACAVIR_TRANSMEMBRANE_TRANSPORT | 9.60e-04 | 5 | 140 | 2 | M27147 | |
| Pathway | REACTOME_G_ALPHA_12_13_SIGNALLING_EVENTS | 1.00e-03 | 77 | 140 | 5 | MM15044 | |
| Pathway | REACTOME_HEMOSTASIS | FN1 IGHV2-70 ITGA10 ITGA3 SLC7A7 SLC7A6 SLC8A1 ADRA2A ADRA2C STXBP2 BSG CD48 IGKV3D-20 ATP2B1 IGKV3-20 IGKV3-11 | 1.15e-03 | 679 | 140 | 16 | M8395 |
| Pathway | REACTOME_G_ALPHA_12_13_SIGNALLING_EVENTS | 1.19e-03 | 80 | 140 | 5 | M800 | |
| Pathway | REACTOME_ROLE_OF_PHOSPHOLIPIDS_IN_PHAGOCYTOSIS | 1.33e-03 | 82 | 140 | 5 | M27110 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ITGA_B_RHOGAP_RHOA_SIGNALING_PATHWAY | 1.47e-03 | 23 | 140 | 3 | M47537 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ITGA_B_RHOGEF_RHOA_SIGNALING_PATHWAY | 1.47e-03 | 23 | 140 | 3 | M47720 | |
| Pathway | REACTOME_NRAGE_SIGNALS_DEATH_THROUGH_JNK | 1.74e-03 | 52 | 140 | 4 | MM14743 | |
| Pathway | REACTOME_ION_CHANNEL_TRANSPORT | 1.87e-03 | 176 | 140 | 7 | MM15718 | |
| Pathway | REACTOME_ACTIVATION_OF_RAC1_DOWNSTREAM_OF_NMDARS | 1.99e-03 | 7 | 140 | 2 | M27947 | |
| Pathway | REACTOME_ION_CHANNEL_TRANSPORT | 2.34e-03 | 183 | 140 | 7 | M997 | |
| Pathway | REACTOME_ACTIVATION_OF_NMDA_RECEPTORS_AND_POSTSYNAPTIC_EVENTS | 2.43e-03 | 94 | 140 | 5 | M2843 | |
| Pathway | REACTOME_FCGR3A_MEDIATED_IL10_SYNTHESIS | 2.55e-03 | 95 | 140 | 5 | M29842 | |
| Pathway | REACTOME_CHEMOKINE_RECEPTORS_BIND_CHEMOKINES | 2.61e-03 | 58 | 140 | 4 | MM14978 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ITGA_B_RHOG_RAC_SIGNALING_PATHWAY | 2.62e-03 | 28 | 140 | 3 | M47655 | |
| Pathway | WP_NEUROINFLAMMATION_AND_GLUTAMATERGIC_SIGNALING | 2.72e-03 | 140 | 140 | 6 | M42572 | |
| Pathway | REACTOME_NRAGE_SIGNALS_DEATH_THROUGH_JNK | 2.78e-03 | 59 | 140 | 4 | M11215 | |
| Pathway | REACTOME_P75_NTR_RECEPTOR_MEDIATED_SIGNALLING | 2.79e-03 | 97 | 140 | 5 | M9400 | |
| Pathway | REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL | 2.88e-03 | 190 | 140 | 7 | M8240 | |
| Pathway | REACTOME_BINDING_AND_UPTAKE_OF_LIGANDS_BY_SCAVENGER_RECEPTORS | 2.92e-03 | 98 | 140 | 5 | M27152 | |
| Pathway | REACTOME_FCGAMMA_RECEPTOR_FCGR_DEPENDENT_PHAGOCYTOSIS | 3.03e-03 | 143 | 140 | 6 | M27107 | |
| Pathway | REACTOME_G_ALPHA_S_SIGNALLING_EVENTS | 3.03e-03 | 143 | 140 | 6 | MM15055 | |
| Pathway | REACTOME_CD22_MEDIATED_BCR_REGULATION | 3.14e-03 | 61 | 140 | 4 | M27581 | |
| Pathway | REACTOME_REGULATION_OF_INSULIN_SECRETION | 3.14e-03 | 61 | 140 | 4 | MM15071 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ITGA_B_TALIN_VINCULIN_SIGNALING_PATHWAY | 3.20e-03 | 30 | 140 | 3 | M47724 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ITGA_B_FAK_RAC_SIGNALING_PATHWAY | 3.20e-03 | 30 | 140 | 3 | M47718 | |
| Pubmed | RAMP1 HTR2B HTR2C TAAR8 CCR2 ADRA1B ADRA2A ADRA2C CCR3 CCR5 CCR7 NMBR | 5.90e-10 | 200 | 178 | 12 | 18240029 | |
| Pubmed | Proteomics strategy to identify substrates of LNX, a PDZ domain-containing E3 ubiquitin ligase. | 8.20e-10 | 60 | 178 | 8 | 22889411 | |
| Pubmed | 3.30e-09 | 5 | 178 | 4 | 9143512 | ||
| Pubmed | 3.30e-09 | 5 | 178 | 4 | 27808089 | ||
| Pubmed | Structure and evolution of RIM-BP genes: identification of a novel family member. | 3.30e-09 | 5 | 178 | 4 | 17855024 | |
| Pubmed | Targeting Lymph Node Niches Enhances Type 1 Immune Responses to Immunization. | 9.87e-09 | 6 | 178 | 4 | 32460031 | |
| Pubmed | Comparative human/murine sequence analysis of the common eliminated region 1 from human 3p21.3. | 2.69e-08 | 18 | 178 | 5 | 12461651 | |
| Pubmed | 4.57e-08 | 8 | 178 | 4 | 15240672 | ||
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | RCE1 PIGN NRM MGAT4B TM9SF1 HMGCR ITGA3 ATP9A DMXL1 IFNGR1 NPTN BSG SLC22A3 FAM3A CSPG4 PVR FADS2 ENG ATP2B1 SLC37A4 SLC39A7 DGAT1 HTT | 5.98e-08 | 1201 | 178 | 23 | 35696571 |
| Pubmed | Systematic protein-protein interaction mapping for clinically relevant human GPCRs. | HTR2B HTR2C UBR4 ATP9A SLC1A4 CCR2 NPTN BSG DHCR24 PKD1 CCR5 IL17RD ATP2B1 SVOP SLC37A4 DGAT1 HTT | 1.30e-07 | 697 | 178 | 17 | 28298427 |
| Pubmed | 1.32e-07 | 3 | 178 | 3 | 25614627 | ||
| Pubmed | 1.32e-07 | 3 | 178 | 3 | 15086398 | ||
| Pubmed | 1.32e-07 | 3 | 178 | 3 | 20220260 | ||
| Pubmed | The G protein-coupled receptor repertoires of human and mouse. | 1.74e-07 | 79 | 178 | 7 | 12679517 | |
| Pubmed | 2.13e-07 | 11 | 178 | 4 | 35148840 | ||
| Pubmed | 3.18e-07 | 12 | 178 | 4 | 21914794 | ||
| Pubmed | 3.95e-07 | 179 | 178 | 9 | 18577758 | ||
| Pubmed | Differential expression of putative transbilayer amphipath transporters. | 4.57e-07 | 13 | 178 | 4 | 11015572 | |
| Pubmed | 5.25e-07 | 4 | 178 | 3 | 10741397 | ||
| Pubmed | RIM-BP3 is a manchette-associated protein essential for spermiogenesis. | 5.25e-07 | 4 | 178 | 3 | 19091768 | |
| Pubmed | 5.25e-07 | 4 | 178 | 3 | 11115360 | ||
| Pubmed | Chemokine Receptor Redundancy and Specificity Are Context Dependent. | 5.25e-07 | 4 | 178 | 3 | 30784579 | |
| Pubmed | Analysis of combinatorial chemokine receptor expression dynamics using multi-receptor reporter mice. | 5.25e-07 | 4 | 178 | 3 | 35699420 | |
| Pubmed | Host-Protozoan Interactions Protect from Mucosal Infections through Activation of the Inflammasome. | 6.38e-07 | 14 | 178 | 4 | 27716507 | |
| Pubmed | Multiple members of a third subfamily of P-type ATPases identified by genomic sequences and ESTs. | 1.31e-06 | 5 | 178 | 3 | 9548971 | |
| Pubmed | 1.31e-06 | 5 | 178 | 3 | 11466387 | ||
| Pubmed | Inflammation induces two types of inflammatory dendritic cells in inflamed lymph nodes. | 1.31e-06 | 5 | 178 | 3 | 29546878 | |
| Pubmed | Genotypes and haplotypes of CCR2 and CCR3 genes in Japanese cedar pollinosis. | 1.31e-06 | 5 | 178 | 3 | 17135764 | |
| Pubmed | 1.31e-06 | 5 | 178 | 3 | 23248310 | ||
| Pubmed | 1.31e-06 | 5 | 178 | 3 | 10877489 | ||
| Pubmed | 1.50e-06 | 17 | 178 | 4 | 24489825 | ||
| Pubmed | 2.61e-06 | 6 | 178 | 3 | 14647058 | ||
| Pubmed | 2.61e-06 | 6 | 178 | 3 | 34798063 | ||
| Pubmed | Polymorphisms in chemokine receptor genes and susceptibility to Kawasaki disease. | 2.61e-06 | 6 | 178 | 3 | 17672867 | |
| Pubmed | 2.61e-06 | 6 | 178 | 3 | 19017998 | ||
| Pubmed | Eotaxin influences the development of embryonic hematopoietic progenitors in the mouse. | 2.61e-06 | 6 | 178 | 3 | 9365121 | |
| Pubmed | 2.61e-06 | 6 | 178 | 3 | 4691517 | ||
| Pubmed | 2.61e-06 | 6 | 178 | 3 | 98179 | ||
| Pubmed | Expression of adrenergic receptors in mouse preimplantation embryos and ovulated oocytes. | 2.61e-06 | 6 | 178 | 3 | 17636168 | |
| Pubmed | 2.61e-06 | 6 | 178 | 3 | 25947375 | ||
| Pubmed | 2.61e-06 | 6 | 178 | 3 | 28120849 | ||
| Pubmed | 2.61e-06 | 6 | 178 | 3 | 15705791 | ||
| Pubmed | Structural interactions between chemokine receptors, gp120 Env and CD4. | 2.61e-06 | 6 | 178 | 3 | 9653051 | |
| Pubmed | CCL5-producing migratory dendritic cells guide CCR5+ monocytes into the draining lymph nodes. | 2.61e-06 | 6 | 178 | 3 | 36946983 | |
| Pubmed | 2.61e-06 | 6 | 178 | 3 | 99744 | ||
| Pubmed | Host genetic influences on highly active antiretroviral therapy efficacy and AIDS-free survival. | 2.61e-06 | 6 | 178 | 3 | 18391751 | |
| Pubmed | MyD88 is required for protection from lethal infection with a mouse-adapted SARS-CoV. | 2.61e-06 | 6 | 178 | 3 | 19079579 | |
| Pubmed | 3.01e-06 | 20 | 178 | 4 | 25340798 | ||
| Pubmed | Quantitative proteomics identifies a Dab2/integrin module regulating cell migration. | 3.44e-06 | 45 | 178 | 5 | 19581412 | |
| Pubmed | 3.71e-06 | 21 | 178 | 4 | 22842622 | ||
| Pubmed | A study of candidate genotypes associated with dyspepsia in a U.S. community. | 4.54e-06 | 7 | 178 | 3 | 16464220 | |
| Pubmed | 4.54e-06 | 7 | 178 | 3 | 9603450 | ||
| Pubmed | Use of alternate coreceptors on primary cells by two HIV-1 isolates. | 4.54e-06 | 7 | 178 | 3 | 15992849 | |
| Pubmed | 4.82e-06 | 84 | 178 | 6 | 15123239 | ||
| Pubmed | 7.24e-06 | 8 | 178 | 3 | 28550204 | ||
| Pubmed | Cardiac function in genetically engineered mice with altered adrenergic receptor signaling. | 7.24e-06 | 8 | 178 | 3 | 9139936 | |
| Pubmed | Staphylococcus aureus Leukocidins Target Endothelial DARC to Cause Lethality in Mice. | 7.24e-06 | 8 | 178 | 3 | 30799265 | |
| Pubmed | The multiple personalities of the chemokine receptor CCR7 in dendritic cells. | 7.24e-06 | 8 | 178 | 3 | 16621978 | |
| Pubmed | 1.08e-05 | 9 | 178 | 3 | 24155889 | ||
| Pubmed | Early cellular mechanisms of type I interferon-driven susceptibility to tuberculosis. | 1.08e-05 | 9 | 178 | 3 | 38029747 | |
| Pubmed | 1.08e-05 | 9 | 178 | 3 | 15901826 | ||
| Pubmed | Adrenergic regulation of AMP-activated protein kinase in brown adipose tissue in vivo. | 1.08e-05 | 9 | 178 | 3 | 21209093 | |
| Pubmed | 1.08e-05 | 9 | 178 | 3 | 38851191 | ||
| Pubmed | 1.08e-05 | 9 | 178 | 3 | 12070001 | ||
| Pubmed | 1.43e-05 | 29 | 178 | 4 | 34678150 | ||
| Pubmed | The human and mouse repertoire of the adhesion family of G-protein-coupled receptors. | 1.43e-05 | 29 | 178 | 4 | 15203201 | |
| Pubmed | 1.43e-05 | 29 | 178 | 4 | 15071553 | ||
| Pubmed | 1.54e-05 | 10 | 178 | 3 | 15919184 | ||
| Pubmed | Embryonic expression and function of the chemokine SDF-1 and its receptor, CXCR4. | 1.54e-05 | 10 | 178 | 3 | 10479460 | |
| Pubmed | Effect of host genetics on incidence of HIV neuroretinal disorder in patients with AIDS. | 1.54e-05 | 10 | 178 | 3 | 20531015 | |
| Pubmed | The DNA sequence, annotation and analysis of human chromosome 3. | 1.70e-05 | 62 | 178 | 5 | 16641997 | |
| Pubmed | Amino acid transport across mammalian intestinal and renal epithelia. | 1.87e-05 | 31 | 178 | 4 | 18195088 | |
| Pubmed | 2.11e-05 | 11 | 178 | 3 | 19303390 | ||
| Pubmed | 2.42e-05 | 33 | 178 | 4 | 19526283 | ||
| Pubmed | International Union of Basic and Clinical Pharmacology. XCIV. Adhesion G protein-coupled receptors. | 2.42e-05 | 33 | 178 | 4 | 25713288 | |
| Pubmed | MON2 CACNA1A KALRN TSPOAP1 UBR4 APBA1 APBA2 SLC1A4 RAB3GAP1 CSE1L BSG ARHGEF7 RAB3GAP2 FADS2 SMPD2 SVOP PCDH8 SLC39A7 | 2.45e-05 | 1139 | 178 | 18 | 36417873 | |
| Pubmed | 2.60e-05 | 2 | 178 | 2 | 28814603 | ||
| Pubmed | 2.60e-05 | 2 | 178 | 2 | 35931226 | ||
| Pubmed | The COOH-terminal domain of huntingtin interacts with RhoGEF kalirin and modulates cell survival. | 2.60e-05 | 2 | 178 | 2 | 29789657 | |
| Pubmed | Feasibility and biological rationale of repurposing sunitinib and erlotinib for dengue treatment. | 2.60e-05 | 2 | 178 | 2 | 29753658 | |
| Pubmed | Tumor-derived soluble CD155 inhibits DNAM-1-mediated antitumor activity of natural killer cells. | 2.60e-05 | 2 | 178 | 2 | 32040157 | |
| Pubmed | 2.60e-05 | 2 | 178 | 2 | 11958683 | ||
| Pubmed | 2.60e-05 | 2 | 178 | 2 | 9257847 | ||
| Pubmed | 2.60e-05 | 2 | 178 | 2 | 19050266 | ||
| Pubmed | Mutations of the catalytic subunit of RAB3GAP cause Warburg Micro syndrome. | 2.60e-05 | 2 | 178 | 2 | 15696165 | |
| Pubmed | A Newly Discovered Antifibrotic Pathway Regulated by Two Fatty Acid Receptors: GPR40 and GPR84. | 2.60e-05 | 2 | 178 | 2 | 29454750 | |
| Pubmed | 2.60e-05 | 2 | 178 | 2 | 19920139 | ||
| Pubmed | Association of CCR5-59029 A/G and CCR2-V64I variants with renal allograft survival. | 2.60e-05 | 2 | 178 | 2 | 19098363 | |
| Pubmed | 2.60e-05 | 2 | 178 | 2 | 23041556 | ||
| Pubmed | 2.60e-05 | 2 | 178 | 2 | 15769362 | ||
| Pubmed | 2.60e-05 | 2 | 178 | 2 | 27974562 | ||
| Pubmed | 2.60e-05 | 2 | 178 | 2 | 33101303 | ||
| Pubmed | 2.60e-05 | 2 | 178 | 2 | 16055130 | ||
| Pubmed | Effects of CCR2 and CCRS polymorphisms on HIV-1 infection in Thai females. | 2.60e-05 | 2 | 178 | 2 | 18197127 | |
| Pubmed | 2.60e-05 | 2 | 178 | 2 | 29378173 | ||
| Pubmed | 2.60e-05 | 2 | 178 | 2 | 1353249 | ||
| Pubmed | 2.60e-05 | 2 | 178 | 2 | 12680626 | ||
| Pubmed | Sensory Neuron Expressed FcγRI Mediates Postinflammatory Arthritis Pain in Female Mice. | 2.60e-05 | 2 | 178 | 2 | 35833115 | |
| Pubmed | 2.60e-05 | 2 | 178 | 2 | 19824873 | ||
| Pubmed | 2.60e-05 | 2 | 178 | 2 | 22908290 | ||
| Interaction | ATP2B2 interactions | 9.88e-07 | 198 | 170 | 11 | int:ATP2B2 | |
| Interaction | GNAQ interactions | 1.94e-05 | 135 | 170 | 8 | int:GNAQ | |
| Interaction | CERS6 interactions | 2.87e-05 | 104 | 170 | 7 | int:CERS6 | |
| Interaction | CCL8 interactions | 3.18e-05 | 22 | 170 | 4 | int:CCL8 | |
| Interaction | CCL7 interactions | 3.18e-05 | 22 | 170 | 4 | int:CCL7 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr3p21 | 4.72e-06 | 316 | 179 | 9 | chr3p21 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | SLAMF8 TNFRSF18 ITGA3 IL18R1 ABCB1 IFNGR1 CCR2 FCGR1A CD226 BSG PVR CD48 CCR3 CCR5 CCR7 ACKR1 ENG | 8.67e-09 | 394 | 138 | 17 | 471 |
| GeneFamily | CD molecules|C-C motif chemokine receptors | 6.58e-07 | 10 | 138 | 4 | 1091 | |
| GeneFamily | Solute carriers | SLC2A9 SLC7A7 SLC7A6 SLC30A2 SLC10A7 SLC1A4 SLC8A1 SLC7A3 SLC22A3 SLC49A3 SLC2A12 SLC37A4 SLC25A17 SLC39A7 | 2.03e-06 | 395 | 138 | 14 | 752 |
| GeneFamily | ATPase phospholipid transporting | 4.15e-06 | 15 | 138 | 4 | 1210 | |
| GeneFamily | Immunoglobulin like domain containing | 1.75e-05 | 193 | 138 | 9 | 594 | |
| GeneFamily | Adrenoceptors | 3.53e-05 | 9 | 138 | 3 | 169 | |
| GeneFamily | Fibronectin type III domain containing | 2.29e-04 | 160 | 138 | 7 | 555 | |
| GeneFamily | Interferon receptors | 5.70e-04 | 5 | 138 | 2 | 599 | |
| GeneFamily | Atypical chemokine receptors | 8.50e-04 | 6 | 138 | 2 | 1090 | |
| GeneFamily | Adhesion G protein-coupled receptors, subfamily G | 1.18e-03 | 7 | 138 | 2 | 917 | |
| GeneFamily | Glutamate ionotropic receptor NMDA type subunits | 1.18e-03 | 7 | 138 | 2 | 1201 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 1.62e-03 | 66 | 138 | 4 | 722 | |
| GeneFamily | G protein-coupled receptors, Class A orphans | 2.99e-03 | 78 | 138 | 4 | 262 | |
| GeneFamily | Immunoglobulin kappa locus at 2p11.2 | 3.75e-03 | 83 | 138 | 4 | 351 | |
| GeneFamily | 5-hydroxytryptamine receptors, G protein-coupled | 4.27e-03 | 13 | 138 | 2 | 170 | |
| GeneFamily | CD molecules|I-set domain containing|Immunoglobulin like domain containing|Interleukin receptors|TIR domain containing | 5.69e-03 | 15 | 138 | 2 | 1296 | |
| GeneFamily | CD molecules|Integrin alpha subunits | 8.17e-03 | 18 | 138 | 2 | 1160 | |
| Coexpression | MILI_PSEUDOPODIA_HAPTOTAXIS_DN | NRM TM9SF1 S1PR2 HMGCR ITGA3 SLC7A6 ATP10A CLDN12 NPTN WIZ BSG ARHGEF7 FAM3A ATP11A ADGRL2 IL17RD SLC39A7 HYAL2 HTT | 1.15e-07 | 681 | 171 | 19 | M5314 |
| Coexpression | MILI_PSEUDOPODIA_HAPTOTAXIS_DN | NRM TM9SF1 S1PR2 HMGCR ITGA3 SLC7A6 ATP10A CLDN12 NPTN WIZ BSG ARHGEF7 FAM3A ATP11A ADGRL2 IL17RD SLC39A7 HYAL2 HTT | 1.88e-07 | 703 | 171 | 19 | MM1055 |
| Coexpression | GSE24634_TEFF_VS_TCONV_DAY3_IN_CULTURE_DN | SLAMF8 SLC2A9 TM9SF1 APBA2 CCRL2 GSAP SLC7A7 OSBPL1A CCR5 CTSO | 8.30e-07 | 200 | 171 | 10 | M4616 |
| Coexpression | HALLMARK_INFLAMMATORY_RESPONSE | 8.30e-07 | 200 | 171 | 10 | M5932 | |
| Coexpression | GSE5589_LPS_VS_LPS_AND_IL10_STIM_MACROPHAGE_180MIN_UP | 7.03e-06 | 200 | 171 | 9 | M6615 | |
| Coexpression | GSE360_L_DONOVANI_VS_B_MALAYI_LOW_DOSE_DC_DN | 7.03e-06 | 200 | 171 | 9 | M5204 | |
| Coexpression | GOLDRATH_NAIVE_VS_EFF_CD8_TCELL_UP | 7.03e-06 | 200 | 171 | 9 | M3035 | |
| Coexpression | MILI_PSEUDOPODIA_CHEMOTAXIS_DN | FN1 TM9SF1 HMGCR ITGA3 SLC7A6 ATP10A SLC1A4 CSPG4 PVR PKD1 SLC39A7 DGAT1 HTT | 1.03e-05 | 457 | 171 | 13 | M1613 |
| Coexpression | MILI_PSEUDOPODIA_CHEMOTAXIS_DN | FN1 TM9SF1 HMGCR ITGA3 SLC7A6 ATP10A SLC1A4 CSPG4 PVR PKD1 SLC39A7 DGAT1 HTT | 1.39e-05 | 470 | 171 | 13 | MM1053 |
| Coexpression | ONO_FOXP3_TARGETS_UP | 1.41e-05 | 23 | 171 | 4 | M1981 | |
| Coexpression | CHEN_METABOLIC_SYNDROM_NETWORK | SLAMF8 TCAF2 HTR2B CAMKK1 CCRL2 S1PR2 TNFRSF18 GSAP SLC7A6 CALHM2 STAB1 IFNAR1 IFNGR1 TYRO3 SLC8A1 STXBP2 FCGR1A FCGR1BP TMPRSS3 CD48 PEDS1 CCR5 IL17RD | 1.63e-05 | 1316 | 171 | 23 | MM1052 |
| Coexpression | ONO_FOXP3_TARGETS_UP | 1.68e-05 | 24 | 171 | 4 | MM1270 | |
| Coexpression | GSE21360_NAIVE_VS_PRIMARY_MEMORY_CD8_TCELL_UP | 1.89e-05 | 173 | 171 | 8 | M7626 | |
| Coexpression | RUTELLA_RESPONSE_TO_HGF_UP | SLAMF8 RAMP1 CCRL2 SLC1A4 CALHM2 RAB3GAP1 FCGR1A DHCR24 PVR OSBPL1A CCR5 CCR7 | 2.23e-05 | 421 | 171 | 12 | M18149 |
| Coexpression | GSE37301_PRO_BCELL_VS_RAG2_KO_NK_CELL_UP | 2.72e-05 | 182 | 171 | 8 | M8899 | |
| Coexpression | PLASARI_TGFB1_TARGETS_10HR_UP | 4.60e-05 | 196 | 171 | 8 | M2445 | |
| Coexpression | PLASARI_TGFB1_TARGETS_10HR_UP | 4.77e-05 | 197 | 171 | 8 | MM1320 | |
| Coexpression | GSE23502_BM_VS_COLON_TUMOR_HDC_KO_MYELOID_DERIVED_SUPPRESSOR_CELL_UP | 5.12e-05 | 199 | 171 | 8 | M8082 | |
| Coexpression | GSE36888_UNTREATED_VS_IL2_TREATED_STAT5_AB_KNOCKIN_TCELL_17H_DN | 5.12e-05 | 199 | 171 | 8 | M8743 | |
| Coexpression | GSE360_CTRL_VS_L_DONOVANI_DC_UP | 5.12e-05 | 199 | 171 | 8 | M5143 | |
| Coexpression | GSE17721_CTRL_VS_CPG_6H_BMDC_UP | 5.31e-05 | 200 | 171 | 8 | M3764 | |
| Coexpression | DESCARTES_ORGANOGENESIS_WHITE_BLOOD_CELLS | RAMP1 IL18R1 STAP1 CALHM2 ABCB1 STAB1 IFNGR1 CCR2 FCGR1A FCGR1BP SLC22A3 CD48 CCR5 ARHGEF6 | 5.49e-05 | 615 | 171 | 14 | MM3641 |
| Coexpression | CHEN_METABOLIC_SYNDROM_NETWORK | SLAMF8 HTR2B CAMKK1 CCRL2 S1PR2 TNFRSF18 GSAP SLC7A6 CALHM2 STAB1 IFNAR1 IFNGR1 TYRO3 SLC8A1 STXBP2 FCGR1A TMPRSS3 CD48 PEDS1 CCR5 IL17RD | 6.31e-05 | 1242 | 171 | 21 | M1920 |
| Coexpression | HOWARD_DENDRITIC_CELL_INACT_MONOV_INFLUENZA_A_INDONESIA_05_2005_H5N1_AGE_18_49YO_1DY_UP | 8.63e-05 | 159 | 171 | 7 | M40998 | |
| Coexpression | GAURNIER_PSMD4_TARGETS | 1.17e-04 | 73 | 171 | 5 | M11428 | |
| Coexpression | ONO_AML1_TARGETS_DN | 1.20e-04 | 39 | 171 | 4 | M1978 | |
| Coexpression | YAGI_AML_WITH_T_8_21_TRANSLOCATION | KDM3B AP3B1 TTC3 SLC1A4 ADRA2C CD226 BSG MED12 ARHGEF6 DGAT1 | 1.75e-04 | 372 | 171 | 10 | M19261 |
| Coexpression | WALLACE_PROSTATE_CANCER_RACE_UP | 1.78e-04 | 303 | 171 | 9 | M10319 | |
| Coexpression | FLETCHER_PBMC_BCG_10W_INFANT_PPD_STIMULATED_VS_UNSTIMULATED_10W_DN | 1.93e-04 | 181 | 171 | 7 | M40912 | |
| Coexpression | ONO_AML1_TARGETS_DN | 1.94e-04 | 44 | 171 | 4 | MM1269 | |
| Coexpression | GSE6259_CD4_TCELL_VS_CD8_TCELL_DN | 2.13e-04 | 184 | 171 | 7 | M6739 | |
| ToppCell | BAL-Control-cDC_0|Control / Compartment, Disease Groups and Clusters | FN1 GSAP SLC7A7 STAB1 NPTN STXBP2 FCGR1A FCGR1BP OSBPL1A SLC49A3 ENG | 5.57e-10 | 199 | 179 | 11 | 4518ffa51ead9da1ddf07bf048b18602e50f0f84 |
| ToppCell | NS-critical-d_16-33-Myeloid-Non-resident_Macrophage|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 8.08e-08 | 190 | 179 | 9 | 4fe9654a9b449ef49ca10b973ac4378dab34cb53 | |
| ToppCell | distal-Hematologic-Natural_Killer_T-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.05e-07 | 196 | 179 | 9 | 05d2a15ba702b07ef59c55891a06da02cdd15f7f | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.15e-07 | 198 | 179 | 9 | c01091ef18e096d792ea2a7a715764a5b215355f | |
| ToppCell | Bronchial-10x5prime-Immune_Myeloid-Macrophage_other-Macro_CCL|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.25e-07 | 200 | 179 | 9 | db7acee26a02c0836923b0a92174f65c51fafab1 | |
| ToppCell | Transverse-(6)_Macrophage-(60)_Macrophage|Transverse / shred on region, Cell_type, and subtype | 1.25e-07 | 200 | 179 | 9 | 2be675684a2958ea609939bb45248bede78a26bc | |
| ToppCell | Transverse-Macrophage-Macrophage|Transverse / Region, Cell class and subclass | 1.25e-07 | 200 | 179 | 9 | 17548806ba38008050244151d1216c69ef8a8310 | |
| ToppCell | RV-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 2.86e-07 | 160 | 179 | 8 | 29c9b4770d0e73d59cffc7937b179484c76b6dcc | |
| ToppCell | RV-13._Vascular_Smooth_Muscle|RV / Chamber and Cluster_Paper | 3.00e-07 | 161 | 179 | 8 | 47b3b7662cbb671ccc086dc0a0cabd65f63eb5a1 | |
| ToppCell | facs-Spleen-nan-3m-Lymphocytic-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.15e-07 | 168 | 179 | 8 | 74dc46738f1d0a448df6c9b8288b515d92697792 | |
| ToppCell | droplet-Trachea-3m-Hematologic-myeloid-granulocyte-granulocyte_l12|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.34e-07 | 169 | 179 | 8 | ae975e982faf2f161fbba8edb919981e54d9ce17 | |
| ToppCell | LPS-IL1RA-Unknown-Endothelial|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.10e-07 | 118 | 179 | 7 | aefad0b35aff980b6a2a98057735442e8a65ab04 | |
| ToppCell | LPS-IL1RA-Unknown|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.10e-07 | 118 | 179 | 7 | 6cb4063b83f867b782080ce5b1199b51bb277f2a | |
| ToppCell | droplet-Kidney-nan-3m-Lymphocytic|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.42e-07 | 174 | 179 | 8 | 0e541581df2d4249270b28ceded6298329013580 | |
| ToppCell | LPS-IL1RA-Myeloid-Dendritic_cells|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.90e-07 | 176 | 179 | 8 | f3bbe8c1a8d132705eac360cf531261271d84588 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.00e-07 | 180 | 179 | 8 | 280ff5c8f292be1b88120db5ff1788b750644856 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.00e-07 | 180 | 179 | 8 | fdbd7c22044d9328a1e06e2f9a4451529d1df767 | |
| ToppCell | RA-13._Vascular_Smooth_Muscle|RA / Chamber and Cluster_Paper | 7.93e-07 | 183 | 179 | 8 | 818fd886e0188091310825f9145fa53328f2c979 | |
| ToppCell | COVID-19-Endothelial_cells-Pulmonary_venous_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 9.33e-07 | 187 | 179 | 8 | 2d20193a6cacdfa4877457c97b0077408942186c | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.33e-07 | 187 | 179 | 8 | 15d6e158562d7d85af3ceaf955439b379c8fce81 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.33e-07 | 187 | 179 | 8 | f62074b631fd45ad299c69d71b09267b04d656ee | |
| ToppCell | facs-Trachea-3m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l20-1|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.71e-07 | 188 | 179 | 8 | aa516273cdde53c8c0295f06830972388f890c97 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical-aged|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.71e-07 | 188 | 179 | 8 | 32f22a4d8cb98fd8b8fa0fbf28ef9266d711d081 | |
| ToppCell | PCW_10-12-Hematologic_Myeloid-Hem_Myeloid_macrophage-im_immature_macrophage1_(2)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.09e-06 | 191 | 179 | 8 | c383ae386bc53e73a683a9543c7dfed2a65257c5 | |
| ToppCell | Bronchial_Brush-Immune-Luminal_Macrophages|Bronchial_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.09e-06 | 191 | 179 | 8 | 88cb6f828407845918c946f8cee5f940cb81800a | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.09e-06 | 191 | 179 | 8 | 04c4d454b57e29a8d1dcdeb4678ce71bdc29b77b | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.09e-06 | 191 | 179 | 8 | ca5669bd6f4a17471acae3eb229f845cc2e08efa | |
| ToppCell | wk_15-18-Hematologic_Lymphocytic-T_&_ILC-ILC2|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.14e-06 | 192 | 179 | 8 | 017f613b1b9c0bd0842e5c1e71d3ac60dd89eadd | |
| ToppCell | (3)_Macrophage_MARCOpos|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 1.14e-06 | 192 | 179 | 8 | b1e2175bd4c02106e52d8f491eea1329ac327ae9 | |
| ToppCell | 390C-Myeloid-Monocyte-CD14+_Monocyte|390C / Donor, Lineage, Cell class and subclass (all cells) | 1.18e-06 | 193 | 179 | 8 | a50ee6110ea272d9d9f41d48bb5d43711cc00a32 | |
| ToppCell | Children_(3_yrs)-Endothelial-capillary_endothelial_cell_(Cap1)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.23e-06 | 194 | 179 | 8 | 40842a7160f337bfc191ee15fbda3e3d38a04c57 | |
| ToppCell | 390C-Myeloid-Monocyte|390C / Donor, Lineage, Cell class and subclass (all cells) | 1.28e-06 | 195 | 179 | 8 | 6f09bfd6394c10c90c23d130a18941bf490e1a8f | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.33e-06 | 196 | 179 | 8 | 1522958a92e0126326a9f0d9fb1c5b5c50b001ea | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.33e-06 | 196 | 179 | 8 | 1c8294014713684b50885e638668f2ce75f357f0 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.33e-06 | 196 | 179 | 8 | 9737a5f006d37b549f281e1863aca558e1e4dc99 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.33e-06 | 196 | 179 | 8 | fa445f4240c521cf04eb2e2f79a5c55fda31209a | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.33e-06 | 196 | 179 | 8 | 802f61e78a9a1030a86c4a980c398a73cd4d1574 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.33e-06 | 196 | 179 | 8 | cecf82cd5e0a3835d655f5e7478578674a63ce25 | |
| ToppCell | Macrophages-HP_01|World / lung cells shred on cell class, cell subclass, sample id | 1.38e-06 | 197 | 179 | 8 | 598fb7a9a8400af49d90807b3155d3cc1c34f505 | |
| ToppCell | 390C-Myeloid-Monocyte-CD16+_Monocyte|390C / Donor, Lineage, Cell class and subclass (all cells) | 1.38e-06 | 197 | 179 | 8 | 01f5f5c34e904cc0146e978cc05ed1cd86a41533 | |
| ToppCell | 3'-Distal_airway-Endothelial-Blood_vessel_EC-capillary_endothelial_cell-EC_general_capillary|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.38e-06 | 197 | 179 | 8 | e3be7758a92f12e0a423394822957e1b7f995110 | |
| ToppCell | Bronchial-10x5prime-Immune_Myeloid-Macrophage_other-Macro_interstitial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.38e-06 | 197 | 179 | 8 | 1a30747a2188a890f58d831030328986b3a4356d | |
| ToppCell | 3'-Distal_airway-Endothelial-Blood_vessel_EC-capillary_endothelial_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.38e-06 | 197 | 179 | 8 | 6ac8d3e3f573e3848ab33e4df66dfaf8f948ea6c | |
| ToppCell | Bronchus_Control_(B.)-Immune-TX-MoAM-3|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 1.43e-06 | 198 | 179 | 8 | 1d92b09aeb03a95fa9e221813002045c4f41dd24 | |
| ToppCell | Bronchial_Biopsy-Immune|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.43e-06 | 198 | 179 | 8 | 1c30eebbe16a331039a9063b93774b5daf518b6e | |
| ToppCell | distal-3-Hematologic-Natural_Killer_T|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.43e-06 | 198 | 179 | 8 | b5da18f2a3554dca36e88be3b96a89089c2f2e1d | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_mature-Endo_capilar-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.43e-06 | 198 | 179 | 8 | 0a4626b51ba8b52acbaf616f0ced850079cd7149 | |
| ToppCell | Bronchial-NucSeq-Endothelial-Endothelia_vascular|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.43e-06 | 198 | 179 | 8 | a1ccbf0e653b2dd665c2254920eb9b37243cc0bd | |
| ToppCell | Mild-Myeloid-Macrophages-FCN1+SPP1+|Mild / Condition, Lineage, Cell class and cell subclass | 1.49e-06 | 199 | 179 | 8 | 2cbaef86af870a228cb46895dd765ea8894c83c5 | |
| ToppCell | Parenchymal-NucSeq-Endothelial-Endothelia_vascular-VE_systemic_venous|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.49e-06 | 199 | 179 | 8 | e2d5c5cab102e67b0131b02392d81adaedc15965 | |
| ToppCell | Tracheal-10x3prime_v2-Endothelial-Endothelia_vascular-VE_alveolar_capillary_Car4_aerocyte|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.49e-06 | 199 | 179 | 8 | 1621ce2968f3100e4c39e0ef8293232a5d76c614 | |
| ToppCell | Transverse-(6)_Macrophage|Transverse / shred on region, Cell_type, and subtype | 1.54e-06 | 200 | 179 | 8 | b28350de555fa756d2631f004f71d5ac69b1affe | |
| ToppCell | Neuronal|World / cells hierarchy compared to all cells using T-Statistic | 1.54e-06 | 200 | 179 | 8 | 48d801219bc771d6c7e151dc88ca4c179988de85 | |
| ToppCell | Tracheal-10x3prime_v2-Immune_Myeloid-Macrophage_other|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.54e-06 | 200 | 179 | 8 | 3cfb28299a55fc1c150262a7333c59a48ae65ad1 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_mature-Endo_capilar|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.54e-06 | 200 | 179 | 8 | c239e6f5d23caa9a59b83e9b352b2d6a691dcb28 | |
| ToppCell | Bronchus_Control_(B.)-Immune-TX-MoAM-1|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 1.54e-06 | 200 | 179 | 8 | fe7f8b04067b6680b69c8523f0fa514ef97207e2 | |
| ToppCell | Tracheal-10x5prime-Immune_Myeloid-Macrophage_other|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.54e-06 | 200 | 179 | 8 | 1438b84096de9b4abe9e6213caa07f6bdff67358 | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-capillary_endothelial_cell-EC_general_capillary-EC_general_capillary_L.2.0.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.54e-06 | 200 | 179 | 8 | ec9a18576a3d08ddfceb70d114c4ab861fbb0d08 | |
| ToppCell | Transverse-Macrophage|Transverse / Region, Cell class and subclass | 1.54e-06 | 200 | 179 | 8 | 1920605e5811938814d02b971069a4506868db5f | |
| ToppCell | (60)_Macrophage|World / shred on Cell_type and subtype | 1.79e-06 | 204 | 179 | 8 | 06d0cb306f1ad0014d81f8228868938e48c2bcf3 | |
| ToppCell | (61)_LYVE1_Macrophage|World / shred on Cell_type and subtype | 1.93e-06 | 206 | 179 | 8 | 711e961a9a03bfd2f0958bd14f25f7f207a2f2b5 | |
| ToppCell | facs-Lung-18m-Hematologic-myeloid-classical_monocyte-classical_monocyte_l2-17-52|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.14e-06 | 146 | 179 | 7 | 26493014daa432db721613ef480d133f3da9eb58 | |
| ToppCell | PND10-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-NK-NK_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.34e-06 | 148 | 179 | 7 | 3aa47398cb805c6c6e16b375cc3e9c7f04bb91f4 | |
| ToppCell | Children_(3_yrs)-Immune-mast_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.46e-06 | 157 | 179 | 7 | ec185dbeabb67fd9ca85f71cab88463b60f9b1c1 | |
| ToppCell | droplet-Kidney-nan-3m-Myeloid-nan|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.76e-06 | 159 | 179 | 7 | bea6e96ba40ebfc1e38687bfa1c61fe227c5a84d | |
| ToppCell | droplet-Bladder-nan-3m-Hematologic-macrophage|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.25e-06 | 162 | 179 | 7 | 0cee9ef405765f3f82d0cd7b8adc88f6e9fdbb5c | |
| ToppCell | droplet-Bladder-nan-3m-Hematologic-leukocyte|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.43e-06 | 163 | 179 | 7 | 2f32a9ab0230fdca98ffa7fd59397301d50e4f30 | |
| ToppCell | droplet-Bladder-nan-3m-Hematologic|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.43e-06 | 163 | 179 | 7 | 6c2967dee563295febe2adabf503d095cb911ccf | |
| ToppCell | droplet-Kidney-nan-24m-Myeloid-macrophage|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.61e-06 | 164 | 179 | 7 | d0b6c29e61d15f4dbe4c1f6e5ed3e10f41f820ab | |
| ToppCell | droplet-Kidney-nan-24m-Myeloid|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.61e-06 | 164 | 179 | 7 | 718cc64b7ef7d03d095be4b2b54c449154da568c | |
| ToppCell | droplet-Kidney-nan-3m-Myeloid-macrophage|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.00e-06 | 166 | 179 | 7 | fc71e871084299fb6f006c76f91e72026a290149 | |
| ToppCell | droplet-Kidney-nan-3m-Myeloid|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.00e-06 | 166 | 179 | 7 | 961f93f7fb127f449cb1021f6ba73775dc666c53 | |
| ToppCell | droplet-Kidney-nan-3m-Myeloid-CD45____macrophage|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.00e-06 | 166 | 179 | 7 | f55fc58572ae6080ac2758462a6b1f3f8b5a93f3 | |
| ToppCell | PND10-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.20e-06 | 167 | 179 | 7 | 84551ee71f9d8d03d514711fc7ca4422c810140b | |
| ToppCell | droplet-Bladder-nan-24m-Hematologic-granulocyte-monocyte_progenitor|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.40e-06 | 168 | 179 | 7 | c6e0daa790dd5db20dd1ab8c1e7142484976d743 | |
| ToppCell | COVID-19_Mild-PLT_2|World / Disease Group and Platelet Clusters | 5.62e-06 | 169 | 179 | 7 | 6abfdc8b437f19c03b408bedc245059d28c6ba6a | |
| ToppCell | facs-Trachea-24m-Hematologic-myeloid-tracheal_macrophage-macrophage_of_tracheal_l12|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.62e-06 | 169 | 179 | 7 | 8180aeda13c511260d0542a94156059d558848a7 | |
| ToppCell | P15-Mesenchymal-mesenchymal_fibroblast-mesenchymal_progenitor_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 5.84e-06 | 170 | 179 | 7 | ba4ba66b624089ed50a9083176386c7941b4c7a3 | |
| ToppCell | facs-Marrow-T-cells-3m-Myeloid-promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.84e-06 | 170 | 179 | 7 | a78d9789c3e7c84a36e1bd380192d7aba4a4d443 | |
| ToppCell | facs-Marrow-T-cells-3m-Myeloid-monocyte_+_promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.84e-06 | 170 | 179 | 7 | ff68600b945b3a5437b14e5411b3db800d0ccbe5 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-monocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.07e-06 | 171 | 179 | 7 | 992df143d76f9e7fb1997a8996f61e941f0f9d4f | |
| ToppCell | LV-13._Vascular_Smooth_Muscle|LV / Chamber and Cluster_Paper | 6.07e-06 | 171 | 179 | 7 | e99ecae66530d1ae09330cee408c8f3950b87e67 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Lymphocytic|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.31e-06 | 172 | 179 | 7 | adf016e5856bc85e7bed58aee09ade483b9dcb00 | |
| ToppCell | Bronchial_Biopsy-Immune-Mast_cells|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X | 6.31e-06 | 172 | 179 | 7 | c477008444d2d71071177807870d7455e90c2fad | |
| ToppCell | droplet-Marrow-BM-30m-Myeloid-monocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.80e-06 | 174 | 179 | 7 | 118ba2729ecc6aa1bb8548f3cf537b3f9e902ef0 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.06e-06 | 175 | 179 | 7 | 12f5fd83c7710fc0c77406f765d9cbd133433b8b | |
| ToppCell | droplet-Marrow-nan-24m-Myeloid-monocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.33e-06 | 176 | 179 | 7 | eddac2ba68d234e3f56f4ca0e11c19bc0e95b6e1 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Hematopoietic-B_cells-CLP|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.33e-06 | 176 | 179 | 7 | f163cc6d632112aad35a0a9217c6c99fbdd1386e | |
| ToppCell | droplet-Marrow-BM_(NON-STC)-30m-Myeloid-monocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.33e-06 | 176 | 179 | 7 | 1bf8fed48bd224f09efe90a38233b1f01d7311fe | |
| ToppCell | droplet-Marrow-nan-21m-Myeloid-monocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.61e-06 | 177 | 179 | 7 | b860013f1fd397400a62d66ab521cfc81349ffe2 | |
| ToppCell | COVID-19-kidney-REN+Pericyte|kidney / Disease (COVID-19 only), tissue and cell type | 8.19e-06 | 179 | 179 | 7 | 342c1cc4444f51b8dcb30d3adc98285a25669c6e | |
| ToppCell | 356C-Myeloid-Macrophage-SPP1+_Macrophage_2|356C / Donor, Lineage, Cell class and subclass (all cells) | 8.49e-06 | 180 | 179 | 7 | b94618c1c2592ecf7da3535294aee9243755247a | |
| ToppCell | normal_Lymph_Node-Myeloid_cells-Pleural_Mac|normal_Lymph_Node / Location, Cell class and cell subclass | 8.80e-06 | 181 | 179 | 7 | 921e917f83105896ad8918dc134b871708024021 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.12e-06 | 182 | 179 | 7 | b7d532feb73167e05475855061b35a209583f44c | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.12e-06 | 182 | 179 | 7 | af65f0fc3f9e5d9ce69ee5faaf5b6cb7f8412e0c | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 9.45e-06 | 183 | 179 | 7 | 3c516fe5083f02bad1f464ed284010b4131a833c | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 9.45e-06 | 183 | 179 | 7 | 9c2689d76fc6d30f5ab093428aa669d0a98953cf | |
| ToppCell | Control-Endothelial_cells-Pulmonary_venous_endothelial_cells|Control / group, cell type (main and fine annotations) | 9.45e-06 | 183 | 179 | 7 | 46be9f96755c7b65aeac061d95d15abeb6466034 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 9.80e-06 | 184 | 179 | 7 | 7294b379ce4cb8fa75e432559082f93cd106aaf5 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.05e-05 | 186 | 179 | 7 | 2ea5ff14861e5f91d0e6a5767c403a24045d715c | |
| Computational | Genes in the cancer module 146. | HTR2B HTR2C GPR39 S1PR2 EDNRA CCR2 ADRA1B ADRA2A CCR3 CCR5 ACKR1 | 2.28e-09 | 102 | 100 | 11 | MODULE_146 |
| Computational | Genes in the cancer module 27. | HTR2B GPR39 ITGA10 S1PR2 ITGA3 GRM2 IL18R1 EDNRA IFNGR1 CCR2 ADRA2A FCGR1A ROS1 CCR5 ADGRL2 ACKR1 HYAL2 | 2.47e-08 | 355 | 100 | 17 | MODULE_27 |
| Computational | Genes in the cancer module 288. | 1.03e-06 | 37 | 100 | 6 | MODULE_288 | |
| Computational | Genes in the cancer module 289. | 2.13e-06 | 124 | 100 | 9 | MODULE_289 | |
| Computational | GPCR signaling pathways (immune and neuro). | 1.94e-05 | 90 | 100 | 7 | MODULE_375 | |
| Computational | Membranal receptors. | HTR2B GPR39 ITGA10 ITGA3 GRM2 IL18R1 EDNRA IFNGR1 CCR2 ADRA2A FCGR1A FADS2 CCR5 HAS2 ACKR1 | 8.02e-05 | 517 | 100 | 15 | MODULE_64 |
| Drug | M100907 | 4.55e-09 | 51 | 173 | 8 | CID000060858 | |
| Drug | Pergolide | 1.37e-07 | 17 | 173 | 5 | DB01186 | |
| Drug | Bromocriptine | 1.89e-07 | 18 | 173 | 5 | DB01200 | |
| Drug | Doxepin | 3.38e-07 | 20 | 173 | 5 | DB01142 | |
| Drug | proanthocyanidin | 4.31e-07 | 3 | 173 | 3 | ctd:C013221 | |
| Drug | Prazosin | 5.01e-07 | 63 | 173 | 7 | ctd:D011224 | |
| Drug | agmatine | 1.13e-06 | 102 | 173 | 8 | CID000000199 | |
| Drug | Dx11 | 1.52e-06 | 12 | 173 | 4 | CID003009361 | |
| Drug | Lisuride | 3.04e-06 | 14 | 173 | 4 | DB00589 | |
| Drug | Pramipexole | 3.04e-06 | 14 | 173 | 4 | DB00413 | |
| Drug | Ropinirole | 3.04e-06 | 14 | 173 | 4 | DB00268 | |
| Drug | Risperidone | 3.04e-06 | 14 | 173 | 4 | DB00734 | |
| Drug | Cabergoline | 4.12e-06 | 15 | 173 | 4 | DB00248 | |
| Drug | Apomorphine | 4.12e-06 | 15 | 173 | 4 | DB00714 | |
| Drug | phenylethylamine | 5.28e-06 | 89 | 173 | 7 | CID000001001 | |
| Drug | AC1L1CLB | 6.59e-06 | 92 | 173 | 7 | CID000001951 | |
| Drug | Paliperidone | 7.09e-06 | 17 | 173 | 4 | DB01267 | |
| Drug | Xylometazoline | 8.48e-06 | 6 | 173 | 3 | DB06694 | |
| Drug | im 24 | 8.48e-06 | 6 | 173 | 3 | CID000131214 | |
| Drug | risperidone | 9.73e-06 | 136 | 173 | 8 | CID000005073 | |
| Drug | Methotrimeprazine | 1.14e-05 | 19 | 173 | 4 | DB01403 | |
| Drug | Lurasidone Hydrochloride | 1.48e-05 | 7 | 173 | 3 | ctd:D000069056 | |
| Drug | xylometazoline | 1.48e-05 | 7 | 173 | 3 | ctd:C009695 | |
| Drug | dibenzosuberane | 1.48e-05 | 7 | 173 | 3 | CID000070029 | |
| Drug | nifedipine | CACNA1A GRIN2C GRM2 KLK3 EDNRA ABCB1 ADRA1B ADRA2A PKD1 FADS2 TACR2 GRIN3B ATP2B1 | 1.84e-05 | 415 | 173 | 13 | CID000004485 |
| Drug | Oxymetazoline | 2.35e-05 | 8 | 173 | 3 | ctd:D010109 | |
| Drug | loxapine | 2.55e-05 | 46 | 173 | 5 | CID000003964 | |
| Drug | etoperidone | 2.55e-05 | 23 | 173 | 4 | CID000040589 | |
| Drug | MAMP | 3.16e-05 | 160 | 173 | 8 | CID000001206 | |
| Drug | Nefazodone | 3.50e-05 | 9 | 173 | 3 | DB01149 | |
| Drug | CHEBI:334542 | 3.50e-05 | 9 | 173 | 3 | CID010884046 | |
| Drug | CHEBI:334375 | 3.50e-05 | 9 | 173 | 3 | CID010476504 | |
| Drug | McN-5707 | 3.50e-05 | 9 | 173 | 3 | CID000126059 | |
| Drug | Olanzapine | 3.60e-05 | 25 | 173 | 4 | DB00334 | |
| Drug | Ziprasidone | 3.60e-05 | 25 | 173 | 4 | DB00246 | |
| Drug | Aripiprazole | 3.60e-05 | 25 | 173 | 4 | DB01238 | |
| Drug | pinolenic acid | 3.60e-05 | 25 | 173 | 4 | CID005312493 | |
| Drug | Clozapine | 4.22e-05 | 26 | 173 | 4 | DB00363 | |
| Drug | Quetiapine | 4.22e-05 | 26 | 173 | 4 | DB01224 | |
| Drug | myo-inositol | PIGN CACNA1A HTR2B HTR2C GPR39 S1PR2 GRM2 EDNRA ADRA1B ADRA2A CEPT1 CSE1L FCGR1A PKD1 TACR2 ATP11A NMBR ATP2B1 | 4.83e-05 | 811 | 173 | 18 | CID000000892 |
| Drug | Norepinephrine | 4.97e-05 | 10 | 173 | 3 | DB00368 | |
| Drug | Yohimbine | 4.97e-05 | 10 | 173 | 3 | DB01392 | |
| Drug | thioxanthene | 4.97e-05 | 10 | 173 | 3 | CID000067495 | |
| Drug | Droxidopa | 4.97e-05 | 10 | 173 | 3 | DB06262 | |
| Drug | 2gst | 5.02e-05 | 86 | 173 | 6 | CID000444461 | |
| Drug | Norepinephrine | 5.07e-05 | 171 | 173 | 8 | ctd:D009638 | |
| Drug | roxindole | 5.72e-05 | 28 | 173 | 4 | CID000219050 | |
| Drug | Ro 60-0175 | 5.74e-05 | 2 | 173 | 2 | ctd:C103848 | |
| Drug | AC1Q1YRG | 5.74e-05 | 2 | 173 | 2 | CID000105432 | |
| Drug | SB 228357 | 5.74e-05 | 2 | 173 | 2 | ctd:C118947 | |
| Drug | SB-228357 | 5.74e-05 | 2 | 173 | 2 | CID000443390 | |
| Drug | AscoTop | 6.59e-05 | 29 | 173 | 4 | CID000005731 | |
| Drug | cyanopindolol | 7.27e-05 | 57 | 173 | 5 | CID000155346 | |
| Drug | AC1L1G8Z | 7.56e-05 | 30 | 173 | 4 | CID000003581 | |
| Drug | AC1L9K72 | PIGN ATP8B1 ATP9A SLC7A7 ABCB1 CEPT1 FADS2 SMPD2 PCDH8 DGAT1 | 7.89e-05 | 290 | 173 | 10 | CID000446872 |
| Drug | morphine hydrochloride | CACNA1A TSPOAP1 CCRL2 HMGCR GRIN2C GRM2 ABCB1 CCR3 TACR2 CCR5 CCR7 HAS2 GRIN3B | 8.33e-05 | 481 | 173 | 13 | CID000004253 |
| Drug | CI-1041 | 9.02e-05 | 12 | 173 | 3 | CID000156328 | |
| Drug | sulpiride | 9.29e-05 | 96 | 173 | 6 | CID000005355 | |
| Drug | AC1L1H8O | 9.31e-05 | 60 | 173 | 5 | CID000005106 | |
| Drug | ritanserin | 1.01e-04 | 61 | 173 | 5 | CID000005074 | |
| Drug | nitrendipine | 1.04e-04 | 98 | 173 | 6 | CID000004507 | |
| Drug | terazosin | 1.11e-04 | 33 | 173 | 4 | CID000005401 | |
| Drug | Depixol | 1.11e-04 | 33 | 173 | 4 | CID000017011 | |
| Drug | A61603 | 1.11e-04 | 33 | 173 | 4 | CID004038180 | |
| Drug | hepta-3 | 1.17e-04 | 13 | 173 | 3 | CID000150893 | |
| Drug | Sordinol | 1.17e-04 | 13 | 173 | 3 | CID000012453 | |
| Drug | pseudococaine | HTR2B HTR2C CCRL2 GRIN2C GRM2 ARHGEF16 ADRA1B ADRA2A CCR3 CCR5 CCR7 HAS2 GRIN3B ATP2B1 | 1.22e-04 | 570 | 173 | 14 | CID000002826 |
| Drug | nimodipine | 1.24e-04 | 145 | 173 | 7 | CID000004497 | |
| Drug | transdihydrolisuride | 1.25e-04 | 34 | 173 | 4 | CID000005406 | |
| Drug | urapidil | 1.25e-04 | 34 | 173 | 4 | CID000005639 | |
| Drug | desmethylsertraline | 1.25e-04 | 34 | 173 | 4 | CID000114743 | |
| Drug | estradiol, USP; Up 200; 0.1uM; HL60; HT_HG-U133A | 1.27e-04 | 195 | 173 | 8 | 2668_UP | |
| Drug | Lithocholic acid [434-13-9]; Up 200; 10.6uM; MCF7; HT_HG-U133A | 1.36e-04 | 197 | 173 | 8 | 3899_UP | |
| Drug | Risperidone | 1.37e-04 | 65 | 173 | 5 | ctd:D018967 | |
| Drug | kainite | 1.40e-04 | 35 | 173 | 4 | CID000164810 | |
| Drug | phendioxan | 1.40e-04 | 35 | 173 | 4 | CID000185453 | |
| Drug | Iobenguane sulfate; Down 200; 10.8uM; PC3; HT_HG-U133A | 1.41e-04 | 198 | 173 | 8 | 7299_DN | |
| Drug | YM348 | 1.48e-04 | 14 | 173 | 3 | CID003045225 | |
| Drug | McN5652 | 1.48e-04 | 14 | 173 | 3 | CID000146919 | |
| Drug | metoprolol | 1.53e-04 | 105 | 173 | 6 | CID000004171 | |
| Drug | molindone | 1.57e-04 | 36 | 173 | 4 | CID000023897 | |
| Drug | hallucinogen | 1.57e-04 | 36 | 173 | 4 | CID000031374 | |
| Drug | Fenfluramine | 1.71e-04 | 3 | 173 | 2 | DB00574 | |
| Drug | Clonidine | 1.71e-04 | 3 | 173 | 2 | DB00575 | |
| Drug | Brimonidine | 1.71e-04 | 3 | 173 | 2 | DB00484 | |
| Drug | Propericiazine | 1.71e-04 | 3 | 173 | 2 | DB01608 | |
| Drug | 9-(2-Deoxy-5-O-Phosphono-Beta-D-Erythro-Pentofuranosyl)-6-(Phosphonooxy)-9h-Purine | 1.71e-04 | 3 | 173 | 2 | CID009549204 | |
| Drug | Me-M | 1.71e-04 | 3 | 173 | 2 | CID000077590 | |
| Drug | Tizanidine | 1.71e-04 | 3 | 173 | 2 | DB00697 | |
| Drug | spiramide | 1.71e-04 | 3 | 173 | 2 | CID000068186 | |
| Drug | WAY-181187 | 1.71e-04 | 3 | 173 | 2 | CID010150497 | |
| Drug | ketanserinol | 1.71e-04 | 3 | 173 | 2 | CID000156394 | |
| Drug | Norfenfluramine | 1.71e-04 | 3 | 173 | 2 | ctd:D009642 | |
| Drug | rilmenidine | 1.75e-04 | 37 | 173 | 4 | CID000068712 | |
| Drug | benzyloxyaspartate | 1.75e-04 | 37 | 173 | 4 | CID004133412 | |
| Drug | fenoldopam | 1.94e-04 | 70 | 173 | 5 | CID000003340 | |
| Drug | fentanyl | 2.07e-04 | 111 | 173 | 6 | CID000003345 | |
| Drug | N-butyl-N-(4-hydroxybutyl)nitrosamine | 2.15e-04 | 39 | 173 | 4 | CID000019665 | |
| Drug | indoline | 2.15e-04 | 39 | 173 | 4 | CID000010328 | |
| Drug | haloperidol | CACNA1A HTR2B HTR2C TSPOAP1 GRIN2C GRM2 ABCB1 ADRA1B ADRA2A GRIN3B HTT | 2.24e-04 | 394 | 173 | 11 | CID000003559 |
| Disease | asthma (is_implicated_in) | 3.04e-05 | 157 | 165 | 7 | DOID:2841 (is_implicated_in) | |
| Disease | Martsolf syndrome | 3.11e-05 | 2 | 165 | 2 | C0796037 | |
| Disease | Warburg micro syndrome (implicated_via_orthology) | 3.11e-05 | 2 | 165 | 2 | DOID:0060237 (implicated_via_orthology) | |
| Disease | epilepsy (implicated_via_orthology) | 3.86e-05 | 163 | 165 | 7 | DOID:1826 (implicated_via_orthology) | |
| Disease | posterior uveitis (is_implicated_in) | 9.29e-05 | 3 | 165 | 2 | DOID:12574 (is_implicated_in) | |
| Disease | periapical granuloma (is_marker_for) | 9.29e-05 | 3 | 165 | 2 | DOID:4617 (is_marker_for) | |
| Disease | monocyte count | MGAT4B FN1 MYO1C KALRN TSPOAP1 CCRL2 S1PR2 DPP8 CCR2 FCGR1A CD226 SLC22A3 PKD1 GPR156 CCR3 MYEOV GSG1L ACKR1 ENG | 1.56e-04 | 1320 | 165 | 19 | EFO_0005091 |
| Disease | COVID-19, osteoarthritis | 1.83e-04 | 20 | 165 | 3 | MONDO_0005178, MONDO_0100096 | |
| Disease | Warburg Sjo Fledelius syndrome | 1.85e-04 | 4 | 165 | 2 | C1838625 | |
| Disease | Warburg micro syndrome | 1.85e-04 | 4 | 165 | 2 | cv:C5442005 | |
| Disease | Nonsyndromic Hearing Loss and Deafness, Autosomal Recessive | 1.92e-04 | 51 | 165 | 4 | cv:CN043650 | |
| Disease | anxiety disorder (implicated_via_orthology) | 2.45e-04 | 22 | 165 | 3 | DOID:2030 (implicated_via_orthology) | |
| Disease | hypertension (biomarker_via_orthology) | 3.02e-04 | 227 | 165 | 7 | DOID:10763 (biomarker_via_orthology) | |
| Disease | Acute Q fever | 3.07e-04 | 5 | 165 | 2 | C0519066 | |
| Disease | Chronic Q Fever | 3.07e-04 | 5 | 165 | 2 | C1443892 | |
| Disease | Q Fever | 3.07e-04 | 5 | 165 | 2 | C0034362 | |
| Disease | Coxiella burnetii Infection | 3.07e-04 | 5 | 165 | 2 | C2973787 | |
| Disease | Grand Mal Status Epilepticus | 5.49e-04 | 67 | 165 | 4 | C0311335 | |
| Disease | Status Epilepticus, Subclinical | 5.49e-04 | 67 | 165 | 4 | C0751522 | |
| Disease | Simple Partial Status Epilepticus | 5.49e-04 | 67 | 165 | 4 | C0751524 | |
| Disease | Non-Convulsive Status Epilepticus | 5.49e-04 | 67 | 165 | 4 | C0751523 | |
| Disease | Petit mal status | 5.49e-04 | 67 | 165 | 4 | C0270823 | |
| Disease | Complex Partial Status Epilepticus | 5.49e-04 | 67 | 165 | 4 | C0393734 | |
| Disease | Status Epilepticus | 5.81e-04 | 68 | 165 | 4 | C0038220 | |
| Disease | familial hemiplegic migraine (implicated_via_orthology) | 6.41e-04 | 7 | 165 | 2 | DOID:0060178 (implicated_via_orthology) | |
| Disease | laurylcarnitine measurement | 6.41e-04 | 7 | 165 | 2 | EFO_0021041 | |
| Disease | neutrophil percentage of leukocytes | KALRN TSPOAP1 MFSD2B IL18R1 SLC8A1 ADRA2A FADS2 CCR3 CCR7 ACKR1 HTT | 6.75e-04 | 610 | 165 | 11 | EFO_0007990 |
| Disease | Hypertensive disease | 7.22e-04 | 190 | 165 | 6 | C0020538 | |
| Disease | pulmonary sarcoidosis (is_marker_for) | 7.56e-04 | 32 | 165 | 3 | DOID:13406 (is_marker_for) | |
| Disease | myocardial infarction | 8.28e-04 | 350 | 165 | 8 | EFO_0000612 | |
| Disease | obstructive sleep apnea (biomarker_via_orthology) | 8.51e-04 | 8 | 165 | 2 | DOID:0050848 (biomarker_via_orthology) | |
| Disease | urticaria (is_implicated_in) | 8.51e-04 | 8 | 165 | 2 | DOID:1555 (is_implicated_in) | |
| Disease | Nonsyndromic genetic hearing loss | 8.84e-04 | 76 | 165 | 4 | cv:C5680182 | |
| Disease | acute lymphoblastic leukemia (is_marker_for) | 9.05e-04 | 34 | 165 | 3 | DOID:9952 (is_marker_for) | |
| Disease | atopic dermatitis (is_marker_for) | 9.85e-04 | 35 | 165 | 3 | DOID:3310 (is_marker_for) | |
| Disease | COVID-19 symptoms measurement | 9.85e-04 | 35 | 165 | 3 | EFO_0600019 | |
| Disease | inflammatory bowel disease | 1.00e-03 | 449 | 165 | 9 | EFO_0003767 | |
| Disease | Coronavirus infectious disease (implicated_via_orthology) | 1.09e-03 | 9 | 165 | 2 | DOID:0080599 (implicated_via_orthology) | |
| Disease | migraine (is_implicated_in) | 1.09e-03 | 9 | 165 | 2 | DOID:6364 (is_implicated_in) | |
| Disease | Cardiomegaly | 1.17e-03 | 82 | 165 | 4 | C0018800 | |
| Disease | Cardiac Hypertrophy | 1.17e-03 | 82 | 165 | 4 | C1383860 | |
| Disease | Pulmonary Fibrosis | 1.34e-03 | 85 | 165 | 4 | C0034069 | |
| Disease | human immunodeficiency virus infectious disease (is_implicated_in) | 1.35e-03 | 39 | 165 | 3 | DOID:526 (is_implicated_in) | |
| Disease | Short Stature, CTCAE | 1.36e-03 | 10 | 165 | 2 | C2919142 | |
| Disease | Short stature | 1.36e-03 | 10 | 165 | 2 | C0349588 | |
| Disease | 2-aminobutyrate measurement | 1.36e-03 | 10 | 165 | 2 | EFO_0020017 | |
| Disease | Schizophrenia | HTR2C APBA2 GRIN2C GRM2 IL18R1 ABCB1 NPTN ADRA2A FADS2 CCR5 PCDH8 TNXB MED12 | 1.45e-03 | 883 | 165 | 13 | C0036341 |
| Disease | neutrophil count | CACNA1A MYO1C TSPOAP1 S1PR2 DPP8 TARS2 CEPT1 CD226 OSBPL1A PKD1 FADS2 GRIN3B ADGRL2 ACKR1 ZNF282 TNXB HTT | 1.97e-03 | 1382 | 165 | 17 | EFO_0004833 |
| Disease | renal fibrosis (biomarker_via_orthology) | 1.98e-03 | 12 | 165 | 2 | DOID:0050855 (biomarker_via_orthology) | |
| Disease | intracranial aneurysm (is_implicated_in) | 1.98e-03 | 12 | 165 | 2 | DOID:10941 (is_implicated_in) | |
| Disease | Kawasaki disease (is_implicated_in) | 1.98e-03 | 12 | 165 | 2 | DOID:13378 (is_implicated_in) | |
| Disease | total lipids in small LDL | 2.32e-03 | 47 | 165 | 3 | EFO_0022168 | |
| Disease | free cholesterol in medium VLDL measurement | 2.32e-03 | 47 | 165 | 3 | EFO_0022269 | |
| Disease | Mood Disorders | 2.60e-03 | 168 | 165 | 5 | C0525045 | |
| Disease | brain ischemia (biomarker_via_orthology) | 2.62e-03 | 102 | 165 | 4 | DOID:2316 (biomarker_via_orthology) | |
| Disease | monocyte percentage of leukocytes | TSPOAP1 MFSD2B CCRL2 DPP8 CCR2 WIZ SLC22A3 PEDS1 FADS2 CCR3 ACKR1 | 2.82e-03 | 731 | 165 | 11 | EFO_0007989 |
| Disease | Malignant neoplasm of breast | RCE1 FN1 KALRN UBR4 ATP8B1 SLC7A7 TTC3 EDNRA ABCB1 EPG5 MAP3K13 NMBR PCDH8 MED12 | 2.93e-03 | 1074 | 165 | 14 | C0006142 |
| Disease | total cholesterol measurement, diastolic blood pressure, triglyceride measurement, systolic blood pressure, hematocrit, ventricular rate measurement, glucose measurement, body mass index, high density lipoprotein cholesterol measurement | 2.94e-03 | 51 | 165 | 3 | EFO_0004340, EFO_0004348, EFO_0004468, EFO_0004530, EFO_0004574, EFO_0004612, EFO_0006335, EFO_0006336, EFO_0007928 | |
| Disease | gallstones | 3.22e-03 | 108 | 165 | 4 | EFO_0004210 | |
| Disease | Familial thoracic aortic aneurysm and aortic dissection | 3.28e-03 | 53 | 165 | 3 | C4707243 | |
| Disease | pulmonary hypertension (implicated_via_orthology) | 3.46e-03 | 54 | 165 | 3 | DOID:6432 (implicated_via_orthology) | |
| Disease | – | 3.54e-03 | 16 | 165 | 2 | 609423 | |
| Disease | Susceptibility to HIV infection | 3.54e-03 | 16 | 165 | 2 | cv:C1836230 | |
| Disease | sarcoidosis (is_implicated_in) | 3.54e-03 | 16 | 165 | 2 | DOID:11335 (is_implicated_in) | |
| Disease | Drug-induced agranulocytosis | 3.54e-03 | 16 | 165 | 2 | HP_0012235 | |
| Disease | HOMA-B | 3.64e-03 | 55 | 165 | 3 | EFO_0004469 | |
| Disease | brain aneurysm | 3.78e-03 | 113 | 165 | 4 | EFO_0003870 | |
| Disease | granulocyte percentage of myeloid white cells | 4.08e-03 | 268 | 165 | 6 | EFO_0007997 | |
| Disease | Adrenocortical carcinoma | 4.48e-03 | 18 | 165 | 2 | C0206686 | |
| Disease | alcohol use disorder (implicated_via_orthology) | 4.90e-03 | 195 | 165 | 5 | DOID:1574 (implicated_via_orthology) | |
| Disease | phosphatidylcholine 34:2 measurement | 5.53e-03 | 20 | 165 | 2 | EFO_0010376 | |
| Disease | end stage renal disease (implicated_via_orthology) | 5.53e-03 | 20 | 165 | 2 | DOID:783 (implicated_via_orthology) | |
| Disease | CCL2 measurement | 5.56e-03 | 126 | 165 | 4 | EFO_0004749 | |
| Disease | pulmonary hypertension (is_marker_for) | 5.57e-03 | 64 | 165 | 3 | DOID:6432 (is_marker_for) | |
| Disease | rheumatoid arthritis, COVID-19 | 5.57e-03 | 64 | 165 | 3 | EFO_0000685, MONDO_0100096 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SIFEVIWAVIKPGTS | 561 | O00555 | |
| LSSLVSWIVAGNITP | 1206 | Q9HCE0 | |
| ITVVWLISIGIAIPV | 176 | P41595 | |
| TSVLAWVTAILATLP | 151 | O00421 | |
| QIVTWLISLGVLESP | 6 | Q15052 | |
| WSIIILDVIEPSGLI | 656 | Q6P2P2 | |
| DSIPHTVVLTVVEGW | 106 | Q6UVK1 | |
| IWELQVSALGSVPLI | 126 | Q6UX41 | |
| AVAVLLPILGTSWVF | 761 | Q6QNK2 | |
| TIVAVWLISAVISFP | 171 | P18825 | |
| LLIVVAWLVVEAPGT | 691 | Q14416 | |
| LAPASEKGVLWLSVV | 126 | Q6UXU4 | |
| IKIDAATGIPVTTWR | 591 | Q9BQL6 | |
| IGLLVWQSDISVSPV | 16 | P28335 | |
| AIVWAISIGVSVPIP | 176 | P28335 | |
| VGWGVPAVVVTIILT | 741 | Q8IZP9 | |
| VTWSQLPEVVELGIL | 261 | Q5VV41 | |
| GIWILATVLSIPELL | 181 | P32248 | |
| VGIWGVAALLTLPVT | 171 | Q16570 | |
| TIDIRSIGVPWTLHT | 811 | A6QL63 | |
| GVHELLLTVITWVGI | 841 | O95490 | |
| LLSVWVLSTVISIGP | 166 | P35368 | |
| IGIPLVTAIEIVSIW | 196 | P25101 | |
| VVVVESGWGSILPTV | 581 | Q99767 | |
| QTVTWLITLGVLESP | 6 | Q14155 | |
| SLIGWGVPAIVVAIT | 571 | Q96K78 | |
| RTLLTSNDTWIVPIL | 601 | Q6Q4G3 | |
| ITWVVAVFASLPGII | 151 | P51681 | |
| AVWLSLIIGQPIAVL | 456 | O75907 | |
| PVSLSWVRDGILVVG | 1216 | Q9Y485 | |
| WPREVLLVLSVNSSV | 91 | P17813 | |
| TLLWGQLISTIPTSR | 1051 | P20020 | |
| WYTTLVPLLVVLGVT | 141 | O43520 | |
| FTWGTPIVTIALLTF | 1201 | O60312 | |
| TVPVARASILWLIGE | 491 | O00203 | |
| PITVTLLVTALVVWQ | 126 | O60894 | |
| LATTWPHLTEGIIVD | 281 | Q15042 | |
| GVLVVSWLPVTIDSA | 1101 | A6NNM3 | |
| GVLVVSWLPVTIDSA | 1101 | A6NJZ7 | |
| LIISWLPVTIDAAGT | 996 | O95153 | |
| VLWLSIGGEVLDIVL | 121 | A8MUP6 | |
| LTFLTVTDLIGLPWV | 516 | Q8TD20 | |
| LLLWLPDTTGEIVLT | 11 | A0A0A0MRZ8 | |
| ISPVLGLSAAVWAKI | 221 | P08183 | |
| WLSVEGPISIVELAL | 1131 | Q9H2M9 | |
| NGWIPTLITAFVLAT | 156 | O95864 | |
| TLLLWVPVDGQVDTT | 6 | Q92637 | |
| QILLGSVLVPTIKSW | 311 | Q0GE19 | |
| IIASWTITIPVVIGE | 136 | Q8NH19 | |
| AWVIGLVESVVQTPS | 146 | O95918 | |
| LPLTLWVLISVSTAE | 6 | Q13478 | |
| GPTVTLALVLAVSWA | 6 | Q12891 | |
| GIWVVSVLLAVPEAV | 166 | P28336 | |
| IGFVWVTSALVALPL | 156 | O43194 | |
| QVAVTILWSPGALGI | 91 | Q8NFM7 | |
| LLLWLPDTTGEIVLT | 11 | A0A0C4DH25 | |
| RLSIQTDSPVWVILS | 526 | Q9UQ53 | |
| LIPITVAEAGLTISW | 1376 | Q9BQS8 | |
| HPWEVIVGTVTLTIC | 16 | P04035 | |
| NSVRLIPSWTTVILV | 436 | Q8N5S9 | |
| WVGITSQIIIGLILS | 971 | P54707 | |
| ILGRAAVAPVTWSVI | 106 | Q9HA72 | |
| AVAPVTWSVISLLRG | 111 | Q9HA72 | |
| VLLWRELTGIQPGTS | 86 | Q9Y256 | |
| LGATTLVLVAVAPWV | 6 | P17181 | |
| AGVVNVLLTTPLWVV | 111 | O43808 | |
| LPAEIELWLVLVAVG | 986 | P26006 | |
| VTLTTMPTVLGVLWL | 71 | Q9H340 | |
| IVGNLSILTLVFWEP | 41 | Q9H343 | |
| TVLTWPVVGRIALAV | 136 | Q96RD2 | |
| GSVLQWDTPLIVIIV | 741 | O95206 | |
| FILGLQAWDTPTIVS | 11 | Q96LB9 | |
| LSWTPFLITGIVQVA | 236 | Q8TDV5 | |
| PVSLGTDIWSIGVLT | 2856 | O60229 | |
| LLARWEDTPLVILGV | 66 | A5PLL7 | |
| EVIVLLLEGSLVWAP | 86 | Q7LBC6 | |
| GLPLRVAGSWLTVVT | 251 | Q96EZ4 | |
| FVSGVSIAVSLLLPW | 376 | A6NFX1 | |
| VLSSLERSGVWLVAP | 1416 | Q93074 | |
| VELLTVLWVVPTLGT | 201 | Q8IXM6 | |
| VLWVVPTLGTDRLLL | 206 | Q8IXM6 | |
| WVPLGFVLAVTVIRE | 106 | O75110 | |
| LTVPSWVLSQVTLRE | 11 | P01814 | |
| TDLLQISLVAPWVVA | 76 | Q96P66 | |
| ISLVAPWVVATSVPL | 81 | Q96P66 | |
| WIPILTITVQGSAKA | 451 | Q7Z3U7 | |
| SESVFIIPGSVLLWR | 821 | Q9BXW6 | |
| LVSTWVVGVASFAPL | 141 | Q9NQS5 | |
| TSATLTWIRPDTILG | 1486 | Q9UMZ3 | |
| VTEFVLTGLTDRPWL | 11 | Q9NZP5 | |
| ITPRLLVDWSTGIAS | 251 | O43283 | |
| GEAAILLWTPSVGLV | 351 | O60906 | |
| ILETTVVIPGSWLSN | 626 | Q3MJ16 | |
| PLRIVVLVVSVGVTW | 6 | P98173 | |
| TVTSDSPKLWILVLG | 321 | O43826 | |
| SVLTWNTEIPGITLV | 491 | A4D1B5 | |
| SWIAPNLITIIGLSI | 81 | Q9Y6K0 | |
| ETWATLLGVLVTQPL | 2466 | P42858 | |
| TSLQWVAEILPSSIR | 376 | A4D2P6 | |
| GLITGAWSVVLNPLV | 261 | O14842 | |
| VTWGLAVLAALPEFI | 156 | P51677 | |
| VDITDSSIGLRWTPL | 1276 | P02751 | |
| QVTALLTSIGWTLPV | 141 | Q15392 | |
| IFRVAIAGAPVTLWI | 771 | Q6V1X1 | |
| LEDLPVGTVIAWLET | 946 | Q8TDW7 | |
| IGLIPVSVWFTILLG | 476 | Q92819 | |
| WPFLGIVAEVLVLVT | 326 | P35613 | |
| SITGRAVIAPLTWLA | 106 | Q5JW98 | |
| IVESGWGSILPTVII | 671 | Q02410 | |
| SVITWLVAVFASVPG | 161 | P41597 | |
| IIIWNVGTGEVLLSL | 156 | Q6QEF8 | |
| TRPILISLWILIGSV | 1116 | O75578 | |
| TLLLWVPVDGQVDTT | 6 | P12314 | |
| TISSLSPVLLGIVWT | 41 | Q8NFN8 | |
| IDPDTLTLLWSVTVS | 101 | Q9NRM0 | |
| LLLWLPDTTGEIVLT | 11 | P04433 | |
| LLLWLPDTTGEIVLT | 11 | P01619 | |
| PAWTEIFGVLSVATI | 356 | Q5D0E6 | |
| FLAGTVSLSPSIWVI | 141 | P56749 | |
| HGRWSVIVIPDVTVS | 201 | Q15762 | |
| VVLVVLAQTAPDGWI | 21 | Q30KQ5 | |
| IASWLVVTVPTILGL | 226 | P09326 | |
| LLSGSVTLRLTPVQW | 91 | O95136 | |
| FLPEGIAWLRTTVAT | 426 | O75751 | |
| PLLSGDLLWTAVVVL | 501 | Q8WY07 | |
| PSTKAVIAGIWLVAL | 146 | P21452 | |
| SSIKGSLWIPVVAAL | 241 | P15260 | |
| LVTSLVVVLLWEAGA | 6 | Q96NZ9 | |
| VLLSIPFVSVPVVWT | 36 | Q8N138 | |
| LTAEEPIVGLVLWAS | 1881 | P98161 | |
| PIVGLVLWASSKVVA | 1886 | P98161 | |
| ILLGLTSDPQWQVVL | 11 | A6NL08 | |
| ILIQTPWSFTGAVIL | 301 | P03905 | |
| WASPLETLLDVLVAV | 151 | O60391 | |
| LSGTVTVTSLWILVP | 196 | P15151 | |
| VSGISFPTTELLRVW | 276 | Q9BW92 | |
| PTLVISQWTEVLGSV | 526 | O15211 | |
| LLWTTLSEFPGVLVT | 376 | Q8N4V2 | |
| LSEFPGVLVTLWIID | 381 | Q8N4V2 | |
| LVLVVSPWSAARGVL | 6 | Q9BYC8 | |
| SVSGICISVSWILPL | 146 | Q969N4 | |
| WGELATDNIILTVPT | 661 | Q9Y4C2 | |
| WGELATDNIILTVPT | 661 | A6NFQ2 | |
| GVLVVSWLPVTIDSA | 1101 | Q9UFD9 | |
| LWRGPVVVAISLATF | 211 | Q8NFT2 | |
| TVRLWSLTALVTPVQ | 676 | Q8IZU2 | |
| GITNWELTVSPINIL | 796 | O95785 | |
| EILPSAWILQPITVE | 4641 | Q9P2P6 | |
| ILWRGLPNVVTSAIS | 1341 | Q92954 | |
| LILVDWGVLSTLGQI | 1546 | Q7RTU9 | |
| VVTPLLESWALSQVA | 16 | Q96GA7 | |
| TVWVISAVISFPPLI | 171 | P08913 | |
| LTFGPLVVIVDAVSW | 236 | P43234 | |
| SSGPAWLAIVLLVTI | 1071 | P98196 | |
| LVVSTPFGVAAIWIL | 76 | Q6UXD7 | |
| LCGGSVITPLWIITA | 241 | P57727 | |
| PRFVTAIWNLLVTTG | 291 | P55060 | |
| TTTEIWTLPQVLGER | 206 | P10745 | |
| PLILAVDWIVDRTTT | 446 | P43007 | |
| VAVGLLTWATLGLLV | 11 | Q92504 | |
| WTSLLIIEPTSQAII | 121 | Q9UM01 | |
| WEVLIGSSHILTPTR | 561 | Q15833 | |
| EWRGFILTVTELSVP | 111 | Q9ULZ2 | |
| LRVVAVTPTTLELGW | 846 | P22105 | |
| PSITWIRAQATISVL | 131 | Q9Y639 | |
| GVLTWPTSNVIIEES | 611 | P53804 | |
| SLLQVEIPGTITSWV | 651 | Q9HBX9 | |
| EIPGTITSWVVIFIL | 656 | Q9HBX9 | |
| LGTGALVVLLTLWIT | 231 | P0DPE3 | |
| APGTVVVSRIIVWDI | 2431 | Q9NY15 | |
| WIPETSFILTIIVGI | 1856 | P08922 | |
| LWEALLPITVTGAQV | 11 | Q9P0V8 | |
| IISWATLASSLVVPL | 686 | O95427 | |
| EPLGWLTVVLLAVAA | 161 | Q9Y5U5 | |
| IRLWVSLLVVEPTGQ | 126 | Q92536 | |
| VWLPGSQTELAIVTA | 2006 | Q5T4S7 | |
| VLLTLCVTAGTPEVW | 31 | Q6DKI7 | |
| LSGILGAVVTWVIEL | 126 | Q6ZQQ6 | |
| RFVSPVTGDLLVITW | 351 | Q6ZQQ6 | |
| VTGDLLVITWPFSIL | 356 | Q6ZQQ6 | |
| RTSWVPVVLGVLTAL | 426 | Q06418 | |
| LPTAEISLWTVVAAI | 91 | Q9UDV7 | |
| LTLTEVVLSGNVLIW | 21 | P0DTE5 | |
| LTVWLLVGFPLTVIG | 416 | O15321 | |
| ILTALEFWSRVTPSI | 2506 | Q9P2D8 | |
| EILGALVSVLSIWVV | 91 | Q9BRI3 | |
| VFLTLSVTWIGAAPL | 6 | P07288 | |
| SVTWIGAAPLILSRI | 11 | P07288 | |
| VESPSWRSTTVLGLL | 406 | O00159 | |
| TWLYIILSVISPGVV | 216 | P32418 | |
| ILSVISPGVVEVWEG | 221 | P32418 | |
| VSWRLLDVVTLELGP | 191 | Q14957 |